Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	dinitrosyl-iron complex binding	GSTA1 GSTA2 GSTA3 GSTA5	3.39e-08	5	183	4	GO:0035731
GeneOntologyMolecularFunction	steroid delta-isomerase activity	GSTA1 GSTA2 GSTA3 GSTA5	2.34e-07	7	183	4	GO:0004769
GeneOntologyMolecularFunction	glutathione transferase activity	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	6.08e-06	29	183	5	GO:0004364
GeneOntologyMolecularFunction	glutathione binding	GSTA1 GSTA2 GSTA3 GSTA5	1.89e-05	18	183	4	GO:0043295
GeneOntologyMolecularFunction	intramolecular oxidoreductase activity, transposing C=C bonds	GSTA1 GSTA2 GSTA3 GSTA5	2.38e-05	19	183	4	GO:0016863
GeneOntologyMolecularFunction	transferase activity, transferring alkyl or aryl (other than methyl) groups	GSTA1 GSTA2 GSTA3 GSTA4 NANS GSTA5	2.63e-05	64	183	6	GO:0016765
GeneOntologyMolecularFunction	oligopeptide binding	GSTA1 GSTA2 GSTA3 GSTA5	2.95e-05	20	183	4	GO:1900750
GeneOntologyMolecularFunction	fatty-acyl-CoA synthase activity	ACSM5 ACSM2A ACSM2B	4.10e-05	8	183	3	GO:0004321
GeneOntologyMolecularFunction	glutathione peroxidase activity	GSTA1 GSTA2 GSTA3 GSTA5	1.18e-04	28	183	4	GO:0004602
GeneOntologyMolecularFunction	medium-chain fatty acid-CoA ligase activity	ACSM5 ACSM2A ACSM2B	1.18e-04	11	183	3	GO:0031956
GeneOntologyMolecularFunction	intramolecular oxidoreductase activity	GSTA1 GSTA2 GSTA3 RPIA GSTA5	1.74e-04	57	183	5	GO:0016860
GeneOntologyMolecularFunction	benzoate-CoA ligase activity	ACSM2A ACSM2B	2.49e-04	3	183	2	GO:0018858
GeneOntologyMolecularFunction	insulin receptor activity	INSRR IGF1R	2.49e-04	3	183	2	GO:0005009
GeneOntologyMolecularFunction	xenobiotic transmembrane transporter activity	ABCA8 ABCB1 ABCB11 SLC29A4	2.55e-04	34	183	4	GO:0042910
GeneOntologyMolecularFunction	ABC-type xenobiotic transporter activity	ABCA8 ABCB1 ABCB11	3.18e-04	15	183	3	GO:0008559
GeneOntologyMolecularFunction	insulin receptor substrate binding	INSRR PTPN11 IGF1R	3.18e-04	15	183	3	GO:0043560
GeneOntologyMolecularFunction	fatty acid binding	FABP4 GSTA1 GSTA2 GSTA3 GSTA5	4.28e-04	69	183	5	GO:0005504
GeneOntologyMolecularFunction	peptidase activator activity	NLRC4 PSME4 PCOLCE2 PSMD14 CTSV	4.58e-04	70	183	5	GO:0016504
GeneOntologyMolecularFunction	decanoate-CoA ligase activity	ACSM2A ACSM2B	4.95e-04	4	183	2	GO:0102391
GeneOntologyMolecularFunction	ATP-dependent activity	ATP6V0C RECQL DNAH7 DICER1 ABCA8 ABCB1 MSH6 SHPRH ABCD4 ABCB11 ACSM5 ACSM2A DNAH9 HSPA9 ACSM2B	5.52e-04	614	183	15	GO:0140657
GeneOntologyMolecularFunction	peptidase regulator activity	CPAMD8 NLRC4 PSME4 GBP5 A2ML1 PCOLCE2 PSMD14 CTSV SERPIND1	6.27e-04	257	183	9	GO:0061134
GeneOntologyMolecularFunction	testosterone 6-beta-hydroxylase activity	CYP3A7 CYP3A4	8.20e-04	5	183	2	GO:0050649
GeneOntologyMolecularFunction	C-acyltransferase activity	ACSM5 ACSM2A ACSM2B	8.92e-04	21	183	3	GO:0016408
GeneOntologyMolecularFunction	metal cluster binding	GSTA1 GSTA2 GSTA3 GSTA5 AIFM3	9.97e-04	83	183	5	GO:0051540
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCA8 ABCB1 ABCD4 ABCB11	1.05e-03	49	183	4	GO:0140359
GeneOntologyMolecularFunction	fatty acid ligase activity	ACSM5 ACSM2A ACSM2B	1.69e-03	26	183	3	GO:0015645
GeneOntologyMolecularFunction	ribosomal protein S6 kinase activity	RPS6KA3 RPS6KA6	1.70e-03	7	183	2	GO:0004711
GeneOntologyMolecularFunction	CoA-ligase activity	ACSM5 ACSM2A ACSM2B	1.88e-03	27	183	3	GO:0016405
GeneOntologyMolecularFunction	isomerase activity	RANBP2 RECQL GSTA1 GSTA2 GSTA3 RPIA GSTA5	2.00e-03	192	183	7	GO:0016853
GeneOntologyMolecularFunction	magnesium ion binding	DIS3L2 RPS6KA3 POLR2A HMGCL NLRC4 MSH6 RPS6KA6 SIK2	2.05e-03	247	183	8	GO:0000287
GeneOntologyMolecularFunction	estrogen 2-hydroxylase activity	CYP3A7 CYP3A4	2.26e-03	8	183	2	GO:0101021
GeneOntologyBiologicalProcess	xenobiotic metabolic process	CYP3A7 CYP3A4 GSTA1 ABCB1 GSTA2 GSTA3 GSTA4 GSTA5 ABCB11 ACSM2B	5.35e-07	141	183	10	GO:0006805
GeneOntologyBiologicalProcess	cellular response to xenobiotic stimulus	CYP3A7 CYP3A4 GSTA1 ABCB1 GSTA2 GSTA3 GSTA4 GSTA5 ABCB11 PPP1R9B ACSM2B	4.94e-06	222	183	11	GO:0071466
Domain	GST_alpha	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	8.32e-11	5	182	5	IPR003080
Domain	GST_C_3	GSTA2 GSTA3 GSTA4 GSTA5	1.75e-06	10	182	4	PF14497
Domain	GST_N	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.91e-06	22	182	5	PF02798
Domain	GST_NTER	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.91e-06	22	182	5	PS50404
Domain	GST_C	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	4.63e-06	26	182	5	IPR004046
Domain	GST_C	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	4.63e-06	26	182	5	PF00043
Domain	Glutathione_S-Trfase_N	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	5.64e-06	27	182	5	IPR004045
Domain	MHD	FCHO2 AP3M1 AP3M2 AP1M1	5.82e-06	13	182	4	PS51072
Domain	MHD	FCHO2 AP3M1 AP3M2 AP1M1	5.82e-06	13	182	4	IPR028565
Domain	Clathrin_mu_CS	AP3M1 AP3M2 AP1M1	1.78e-05	6	182	3	IPR018240
Domain	CLAT_ADAPTOR_M_1	AP3M1 AP3M2 AP1M1	1.78e-05	6	182	3	PS00990
Domain	CLAT_ADAPTOR_M_2	AP3M1 AP3M2 AP1M1	1.78e-05	6	182	3	PS00991
Domain	GST_CTER	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.84e-05	34	182	5	PS50405
Domain	Glutathione-S-Trfase_C-like	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	3.66e-05	39	182	5	IPR010987
Domain	-	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	3.66e-05	39	182	5	1.20.1050.10
Domain	Aha1_N	AHSA2P AHSA1	9.44e-05	2	182	2	PF09229
Domain	Aha1_N	AHSA2P AHSA1	9.44e-05	2	182	2	SM01000
Domain	VCAM-1	CD22 VCAM1	9.44e-05	2	182	2	IPR003989
Domain	TRPV5/TRPV6	TRPV6 TRPV5	9.44e-05	2	182	2	IPR008344
Domain	AHSA1_N	AHSA2P AHSA1	9.44e-05	2	182	2	IPR015310
Domain	Clathrin_mu	AP3M1 AP3M2 AP1M1	1.04e-04	10	182	3	IPR001392
Domain	DHR-1_domain	DOCK4 DOCK7 DOCK6	1.42e-04	11	182	3	IPR027007
Domain	DHR_2	DOCK4 DOCK7 DOCK6	1.42e-04	11	182	3	PS51651
Domain	DHR_1	DOCK4 DOCK7 DOCK6	1.42e-04	11	182	3	PS51650
Domain	DHR-2	DOCK4 DOCK7 DOCK6	1.42e-04	11	182	3	PF06920
Domain	DOCK	DOCK4 DOCK7 DOCK6	1.42e-04	11	182	3	IPR026791
Domain	Adap_comp_sub	AP3M1 AP3M2 AP1M1	1.42e-04	11	182	3	PF00928
Domain	DOCK_C	DOCK4 DOCK7 DOCK6	1.42e-04	11	182	3	IPR010703
Domain	DOCK-C2	DOCK4 DOCK7 DOCK6	1.42e-04	11	182	3	PF14429
Domain	DHR-2	DOCK4 DOCK7 DOCK6	1.42e-04	11	182	3	IPR027357
Domain	Tyr_kinase_insulin-like_rcpt	INSRR IGF1R	2.82e-04	3	182	2	IPR016246
Domain	AP_mu_sigma_su	AP3M1 AP3M2 AP1M1	4.64e-04	16	182	3	IPR022775
Domain	Clat_adaptor_s	AP3M1 AP3M2 AP1M1	4.64e-04	16	182	3	PF01217
Domain	LAM_G_DOMAIN	FAT4 FAT3 CELSR3 CELSR2	4.97e-04	38	182	4	PS50025
Domain	AMP-bd_C	ACSM5 ACSM2A ACSM2B	5.60e-04	17	182	3	IPR025110
Domain	AMP-binding_C	ACSM5 ACSM2A ACSM2B	5.60e-04	17	182	3	PF13193
Domain	Laminin_G_2	FAT4 FAT3 CELSR3 CELSR2	6.06e-04	40	182	4	PF02210
Domain	LamG	FAT4 FAT3 CELSR3 CELSR2	8.74e-04	44	182	4	SM00282
Domain	Cyt_P450_E_grp-II	CYP3A7 CYP3A4	9.26e-04	5	182	2	IPR002402
Domain	-	RECQL DNAH7 DICER1 ABCA8 NLRC4 ABCB1 MSH6 GSPT2 RHOBTB1 GBP5 MPP4 SHPRH ABCD4 EIF5B ABCB11 DNAH9 GNL3	1.03e-03	746	182	17	3.40.50.300
Domain	fn3	EPHB2 NRCAM SPEG INSRR IGF1R PTPRG IL23R	1.07e-03	162	182	7	PF00041
Domain	ABC_tran	ABCA8 ABCB1 ABCD4 ABCB11	1.21e-03	48	182	4	PF00005
Domain	ABC_TRANSPORTER_2	ABCA8 ABCB1 ABCD4 ABCB11	1.21e-03	48	182	4	PS50893
Domain	ABC_TRANSPORTER_1	ABCA8 ABCB1 ABCD4 ABCB11	1.31e-03	49	182	4	PS00211
Domain	Cyt_P450_E_CYP3A	CYP3A7 CYP3A4	1.38e-03	6	182	2	IPR008072
Domain	RIH_assoc-dom	RYR3 ITPR1	1.38e-03	6	182	2	IPR013662
Domain	Ins145_P3_rec	RYR3 ITPR1	1.38e-03	6	182	2	PF08709
Domain	DUF3398	DOCK7 DOCK6	1.38e-03	6	182	2	PF11878
Domain	RIH_assoc	RYR3 ITPR1	1.38e-03	6	182	2	PF08454
Domain	RIH_dom	RYR3 ITPR1	1.38e-03	6	182	2	IPR000699
Domain	Ins145_P3_rcpt	RYR3 ITPR1	1.38e-03	6	182	2	IPR014821
Domain	Ryanodine_recept-rel	RYR3 ITPR1	1.38e-03	6	182	2	IPR015925
Domain	-	RYR3 ITPR1	1.38e-03	6	182	2	1.25.10.30
Domain	RYDR_ITPR	RYR3 ITPR1	1.38e-03	6	182	2	PF01365
Domain	DOCK_C/D_N	DOCK7 DOCK6	1.38e-03	6	182	2	IPR021816
Domain	Ribosomal_S6_kinase_II	RPS6KA3 RPS6KA6	1.38e-03	6	182	2	IPR016239
Domain	ABC_transporter-like	ABCA8 ABCB1 ABCD4 ABCB11	1.42e-03	50	182	4	IPR003439
Domain	APC_su10/DOC_dom	CUL9 ZZEF1	1.92e-03	7	182	2	IPR004939
Domain	DOC	CUL9 ZZEF1	1.92e-03	7	182	2	PS51284
Domain	Recep_L_domain	INSRR IGF1R	1.92e-03	7	182	2	PF01030
Domain	ANAPC10	CUL9 ZZEF1	1.92e-03	7	182	2	PF03256
Domain	Furin-like	INSRR IGF1R	1.92e-03	7	182	2	PF00757
Domain	Rcpt_L-dom	INSRR IGF1R	1.92e-03	7	182	2	IPR000494
Domain	Furin-like_Cys-rich_dom	INSRR IGF1R	1.92e-03	7	182	2	IPR006211
Domain	-	INSRR IGF1R	1.92e-03	7	182	2	3.80.20.20
Domain	APC10	CUL9 ZZEF1	1.92e-03	7	182	2	SM01337
Domain	AMP-binding_CS	ACSM5 ACSM2A ACSM2B	2.01e-03	26	182	3	IPR020845
Domain	FN3	EPHB2 NRCAM SPEG INSRR IGF1R PTPRG IL23R	2.28e-03	185	182	7	SM00060
Domain	Laminin_G	FAT4 FAT3 CELSR3 CELSR2	2.46e-03	58	182	4	IPR001791
Domain	Longin-like_dom	AP3M1 AP3M2 AP1M1	2.49e-03	28	182	3	IPR011012
Domain	ABC_TM1F	ABCB1 ABCD4 ABCB11	2.49e-03	28	182	3	PS50929
Domain	AMP_BINDING	ACSM5 ACSM2A ACSM2B	2.49e-03	28	182	3	PS00455
Domain	ABC1_TM_dom	ABCB1 ABCD4 ABCB11	2.49e-03	28	182	3	IPR011527
Domain	MacrogloblnA2_thiol-ester-bond	CPAMD8 A2ML1	2.54e-03	8	182	2	IPR019565
Domain	Thiol-ester_cl	CPAMD8 A2ML1	2.54e-03	8	182	2	PF10569
Domain	MacrogloblnA2_CS	CPAMD8 A2ML1	2.54e-03	8	182	2	IPR019742
Domain	A2M_N_2	CPAMD8 A2ML1	2.54e-03	8	182	2	SM01359
Domain	-	CPAMD8 A2ML1	2.54e-03	8	182	2	2.60.40.690
Domain	A2M_recep	CPAMD8 A2ML1	2.54e-03	8	182	2	SM01361
Domain	A2M	CPAMD8 A2ML1	2.54e-03	8	182	2	SM01360
Domain	AAA	DNAH7 ABCA8 ABCB1 ABCD4 ABCB11 DNAH9	2.90e-03	144	182	6	SM00382
Domain	AAA+_ATPase	DNAH7 ABCA8 ABCB1 ABCD4 ABCB11 DNAH9	2.90e-03	144	182	6	IPR003593
Domain	AMP-binding	ACSM5 ACSM2A ACSM2B	3.04e-03	30	182	3	PF00501
Domain	AMP-dep_Synth/Lig	ACSM5 ACSM2A ACSM2B	3.04e-03	30	182	3	IPR000873
Domain	FN3	EPHB2 NRCAM SPEG INSRR IGF1R PTPRG IL23R	3.42e-03	199	182	7	PS50853
Domain	P-loop_NTPase	RECQL DNAH7 DICER1 ABCA8 NLRC4 ABCB1 MSH6 GSPT2 RHOBTB1 GBP5 MPP4 SHPRH ABCD4 EIF5B ABCB11 DNAH9 GNL3	3.91e-03	848	182	17	IPR027417
Domain	MIR	RYR3 ITPR1	4.04e-03	10	182	2	PF02815
Domain	A2M	CPAMD8 A2ML1	4.04e-03	10	182	2	PF00207
Domain	MIR_motif	RYR3 ITPR1	4.04e-03	10	182	2	IPR016093
Domain	A2M_N_2	CPAMD8 A2ML1	4.04e-03	10	182	2	IPR011625
Domain	A2M_comp	CPAMD8 A2ML1	4.04e-03	10	182	2	IPR011626
Domain	A2M_recep	CPAMD8 A2ML1	4.04e-03	10	182	2	PF07677
Domain	A2M_comp	CPAMD8 A2ML1	4.04e-03	10	182	2	PF07678
Domain	A2M_N	CPAMD8 A2ML1	4.04e-03	10	182	2	PF01835
Domain	MIR	RYR3 ITPR1	4.04e-03	10	182	2	PS50919
Domain	MIR	RYR3 ITPR1	4.04e-03	10	182	2	SM00472
Domain	A2M_N	CPAMD8 A2ML1	4.04e-03	10	182	2	IPR002890
Domain	A-macroglobulin_rcpt-bd	CPAMD8 A2ML1	4.04e-03	10	182	2	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	CPAMD8 A2ML1	4.04e-03	10	182	2	PS00477
Domain	A2M_N_2	CPAMD8 A2ML1	4.04e-03	10	182	2	PF07703
Pathway	WP_TRANSCRIPTIONAL_ACTIVATION_BY_NFE2L2_IN_RESPONSE_TO_PHYTOCHEMICALS	EPHB2 GSTA1 GSTA2 GSTA3 GSTA5	5.43e-07	17	142	5	MM15891
Pathway	KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.00e-06	19	142	5	M47809
Pathway	KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.81e-06	23	142	5	M47806
Pathway	REACTOME_DRUG_ADME	CYP3A4 GSTA1 ABCB1 GSTA2 GSTA3 GSTA5 ACSM5 ACSM2A ACSM2B	3.13e-06	119	142	9	MM15692
Pathway	KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	3.52e-06	24	142	5	M47487
Pathway	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	6.40e-06	70	142	7	M16794
Pathway	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	7.74e-06	72	142	7	M9257
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5 ACSM5 ACSM2A ACSM2B	1.40e-05	109	142	8	M18788
Pathway	REACTOME_CONJUGATION_OF_SALICYLATE_WITH_GLYCINE	ACSM5 ACSM2A ACSM2B	1.96e-05	6	142	3	MM14693
Pathway	REACTOME_GLUTATHIONE_CONJUGATION	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.83e-05	36	142	5	M1443
Pathway	REACTOME_AMINO_ACID_CONJUGATION	ACSM5 ACSM2A ACSM2B	3.40e-05	7	142	3	MM14598
Pathway	REACTOME_HEME_DEGRADATION	GSTA1 GSTA2 GSTA3 GSTA5	4.22e-05	20	142	4	MM14721
Pathway	WP_ESTROGEN_METABOLISM	GSTA1 GSTA2 GSTA3 GSTA5	6.27e-05	22	142	4	MM15888
Pathway	BIOCARTA_ARENRF2_PATHWAY	GSTA1 GSTA2 GSTA3 GSTA5	6.27e-05	22	142	4	MM1449
Pathway	REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS	RANBP2 SLC22A12 RHAG PSME4 SLC12A3 ABCD4 SLC17A8 ABCB11 PSMD14	7.56e-05	177	142	9	M27476
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5 ACSM5 ACSM2A ACSM2B	7.72e-05	220	142	10	M10320
Pathway	REACTOME_AMINO_ACID_CONJUGATION	ACSM5 ACSM2A ACSM2B	8.04e-05	9	142	3	M26968
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	GSTA1 GSTA2 GSTA3 GSTA5 ACSM5 ACSM2A ACSM2B	1.02e-04	107	142	7	MM14595
Pathway	REACTOME_DRUG_ADME	CYP3A4 GSTA1 ABCB1 GSTA2 ACSM5 ACSM2A ACSM2B	1.15e-04	109	142	7	M45012
Pathway	KEGG_GLUTATHIONE_METABOLISM	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.42e-04	50	142	5	M1840
Pathway	WP_GLUTATHIONE_METABOLISM	GSTA1 GSTA2 GSTA3 GSTA5	1.45e-04	27	142	4	MM15908
Pathway	REACTOME_AZATHIOPRINE_ADME	GSTA1 GSTA2 GSTA3 GSTA5	1.45e-04	27	142	4	MM15693
Pathway	REACTOME_METABOLISM_OF_PORPHYRINS	GSTA1 GSTA2 GSTA3 GSTA5	2.85e-04	32	142	4	MM14719
Pathway	WP_PREGNANE_X_RECEPTOR_PATHWAY	CYP3A7 CYP3A4 ABCB1 GSTA2	2.85e-04	32	142	4	M39567
Pathway	WP_NUCLEAR_RECEPTORS_METAPATHWAY	CYP3A7 CYP3A4 SLC2A7 GSTA1 ABCB1 GSTA2 GSTA3 GSTA4 SLC6A11 GSTA5 ABCB11	3.36e-04	314	142	11	M39428
Pathway	WP_NRF2_PATHWAY	SLC2A7 GSTA1 GSTA2 GSTA3 GSTA4 SLC6A11 GSTA5	5.58e-04	141	142	7	M39454
Pathway	REACTOME_GLUTATHIONE_CONJUGATION	GSTA1 GSTA2 GSTA3 GSTA5	5.58e-04	38	142	4	MM14600
Pathway	WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY	CYP3A4 ABCB1 ABCB11	6.14e-04	17	142	3	M39666
Pubmed	Hybridization of alpha class subunits generating a functional glutathione transferase A1-4 heterodimer.	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	4.15e-12	5	186	5	11851347
Pubmed	Exceptional activity of murine glutathione transferase A1-1 against (7R,8S)-dihydroxy-(9S,10R)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene-induced DNA damage in stably transfected cells.	GSTA1 GSTA2 GSTA3 GSTA5	7.92e-10	4	186	4	12557262
Pubmed	Complementary DNA cloning, messenger RNA expression, and induction of alpha-class glutathione S-transferases in mouse tissues.	GSTA1 GSTA2 GSTA3 GSTA5	7.92e-10	4	186	4	1728405
Pubmed	Glutathione S-transferase A1 (GSTA1) release, an early indicator of acute hepatic injury in mice.	GSTA1 GSTA2 GSTA3 GSTA5	7.92e-10	4	186	4	24964013
Pubmed	Regulation of mouse glutathione S-transferases by chemoprotectors. Molecular evidence for the existence of three distinct alpha-class glutathione S-transferase subunits, Ya1, Ya2, and Ya3, in mouse liver.	GSTA1 GSTA2 GSTA3 GSTA5	7.92e-10	4	186	4	2049074
Pubmed	Mouse glutathione S-transferase Ya subunit: gene structure and sequence.	GSTA1 GSTA2 GSTA3 GSTA5	7.92e-10	4	186	4	3652905
Pubmed	In situ hybridization of a rat cDNA probe for glutathione S-transferase gene Ya subunit (GST Ya) to rat chromosome 8.	GSTA1 GSTA2 GSTA3 GSTA5	7.92e-10	4	186	4	1526290
Pubmed	Essential roles of ERKs and p38K in up-regulation of GST A1 expression by Maotai content in human hepatoma cell line Hep3B.	GSTA1 GSTA2 GSTA3 GSTA5	7.92e-10	4	186	4	16786188
Pubmed	Glutathione S-transferase Ya subunit is coded by a multigene family located on a single mouse chromosome.	GSTA1 GSTA2 GSTA3 GSTA5	7.92e-10	4	186	4	6330685
Pubmed	Methyl methacrylate activates the Gsta1 promoter.	GSTA1 GSTA2 GSTA3 GSTA5	7.92e-10	4	186	4	19029078
Pubmed	Glutathione S-transferase A1 - a sensitive marker of alcoholic injury on primary hepatocytes.	GSTA1 GSTA2 GSTA3 GSTA5	7.92e-10	4	186	4	27198676
Pubmed	Cloning, expression, and biochemical characterization of a functionally novel alpha class glutathione S-transferase with exceptional activity in the glutathione conjugation of (+)-anti-7,8-dihydroxy-9,10-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene.	GSTA1 GSTA2 GSTA3 GSTA5	7.92e-10	4	186	4	9606968
Pubmed	5'-flanking sequence of mouse glutathione S-transferase Ya gene.	GSTA1 GSTA2 GSTA3 GSTA5	7.92e-10	4	186	4	2893339
Pubmed	Tissue-specific expression and subcellular distribution of murine glutathione S-transferase class kappa.	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.87e-09	11	186	5	15100242
Pubmed	Multiple isoforms of mitochondrial glutathione S-transferases and their differential induction under oxidative stress.	GSTA1 GSTA2 GSTA3 GSTA5	3.94e-09	5	186	4	12020353
Pubmed	Transcriptional regulation of the NAD(P)H:quinone oxidoreductase 1 and glutathione S-transferase ya genes by mercury, lead, and copper.	GSTA1 GSTA2 GSTA3 GSTA5	3.94e-09	5	186	4	16243960
Pubmed	Protein depletion and refeeding change the proportion of mouse liver glutathione S-transferase subunits.	GSTA1 GSTA2 GSTA3 GSTA5	3.94e-09	5	186	4	9268051
Pubmed	Human glutathione S-transferase A (GSTA) family genes are regulated by steroidogenic factor 1 (SF-1) and are involved in steroidogenesis.	GSTA1 GSTA2 GSTA3 GSTA4	3.94e-09	5	186	4	23650189
Pubmed	Tissue-specific induction of murine glutathione transferase mRNAs by butylated hydroxyanisole.	GSTA1 GSTA2 GSTA3 GSTA5	3.94e-09	5	186	4	3417659
Pubmed	Expression pattern of GSTP1 and GSTA1 in the pathogenesis of asthma.	GSTA1 GSTA2 GSTA3 GSTA5	3.94e-09	5	186	4	23647087
Pubmed	Zonal expression and activity of glutathione S-transferase enzymes in the mouse olfactory mucosa.	GSTA1 GSTA2 GSTA3 GSTA5	1.18e-08	6	186	4	14672804
Pubmed	Genetic mapping and systematic screening of mouse endogenously imprinted loci detected with restriction landmark genome scanning method (RLGS).	GSTA1 GSTA2 GSTA3 GSTA5	2.74e-08	7	186	4	7894162
Pubmed	The mouse alpha 1(XII) and human alpha 1(XII)-like collagen genes are localized on mouse chromosome 9 and human chromosome 6.	GSTA1 GSTA2 GSTA3 GSTA5	2.74e-08	7	186	4	1427837
Pubmed	Developmental changes in the cellular distribution of glutathione and glutathione S-transferases in the murine nervous system.	GSTA1 GSTA2 GSTA3 GSTA5	2.74e-08	7	186	4	8584275
Pubmed	Short-chain 3-hydroxyacyl-coenzyme A dehydrogenase associates with a protein super-complex integrating multiple metabolic pathways.	ATP6V0C HMGCL GSTA1 GSTA2 GSTA3 GSTA5 FH ACSM2A ACSM2B	4.25e-08	132	186	9	22496890
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	DOCK4 RANBP2 EMC3 NRCAM HMGCL AP3M1 ITPR1 SLC6A11 GSPT2 CELSR2 MAP1S ABI2 GLYR1 DOCK7 AP1M1 ELAVL4 PPP1R9B EIF4G3 PYCR2 PSMD14 TIMM44 HNRNPLL HSPA9	5.25e-08	1139	186	23	36417873
Pubmed	The use of restriction landmark genomic scanning to scan the mouse genome for endogenous loci with imprinted patterns of methylation.	GSTA1 GSTA2 GSTA3 GSTA5	5.45e-08	8	186	4	7774561
Pubmed	Effects of exposure in utero to bisphenol a on the expression of aryl hydrocarbon receptor, related factors, and xenobiotic metabolizing enzymes in murine embryos.	GSTA1 GSTA2 GSTA3 GSTA5	5.45e-08	8	186	4	16284450
Pubmed	Genetic susceptibility to distinct bladder cancer subphenotypes.	ANKK1 CYP3A7 CYP3A4 HMGCR OPRD1 ABCB1 GSTA4 MSH6 IGF1R BRCA1 ABCB11 IL1RN VCAM1 NPAT	7.31e-08	421	186	14	19692168
Pubmed	Mapping genes encoding drug-metabolizing enzymes in recombinant inbred mice.	GSTA1 GSTA2 GSTA3 GSTA5	9.77e-08	9	186	4	1685137
Pubmed	Association study between single-nucleotide polymorphisms in 199 drug-related genes and commonly measured quantitative traits of 752 healthy Japanese subjects.	CYP3A7 CYP3A4 ABCA8 GSTA1 ABCB1 GSTA2 GSTA3 GSTA4 ABCD4 ABCB11	1.01e-07	193	186	10	19343046
Pubmed	Comparative expression of two alpha class glutathione S-transferases in human adult and prenatal liver tissues.	GSTA1 GSTA2 GSTA4	1.51e-07	3	186	3	12093480
Pubmed	Mapping of class alpha glutathione S-transferase 2 (GST-2) genes to the vicinity of the d locus on mouse chromosome 9.	GSTA1 GSTA2 GSTA3 GSTA5	1.62e-07	10	186	4	1981995
Pubmed	Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.	GSTA1 GSTA2 GSTA3 GSTA5	1.62e-07	10	186	4	15870285
Pubmed	Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo.	GSTA1 GSTA2 GSTA3 GSTA5	2.54e-07	11	186	4	21554947
Pubmed	MEK2 is a kinase related to MEK1 and is differentially expressed in murine tissues.	GSTA1 GSTA2 GSTA3 GSTA5	3.79e-07	12	186	4	8297798
Pubmed	Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy.	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	5.30e-07	30	186	5	20200426
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	SPEG POLR2A RECQL NEB CCDC57 AP3M1 RYR3 VPS13D RPIA IGF1R GRID2IP MAP1S SHPRH DIAPH2	5.43e-07	497	186	14	36774506
Pubmed	The cut-homeodomain transcriptional activator HNF-6 is coexpressed with its target gene HNF-3 beta in the developing murine liver and pancreas.	GSTA1 GSTA2 GSTA3 GSTA5	5.45e-07	13	186	4	9441664
Pubmed	Maternal Calorie Restriction Induces a Transcriptional Cytoprotective Response in Embryonic Liver Partially Dependent on Nrf2.	GSTA1 GSTA2 GSTA3 GSTA5	5.45e-07	13	186	4	36421460
Pubmed	A molecular genetic linkage map of mouse chromosome 9 with regional localizations for the Gsta, T3g, Ets-1 and Ldlr loci.	GSTA1 GSTA2 GSTA3 GSTA5	5.45e-07	13	186	4	2572508
Pubmed	Structure and organization of the human alpha class glutathione S-transferase genes and related pseudogenes.	GSTA1 GSTA2 GSTA3	6.00e-07	4	186	3	8307579
Pubmed	CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients.	CYP3A7 CYP3A4 ABCB1	6.00e-07	4	186	3	18978522
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	DOCK4 RANBP2 MLXIP FCHO2 NEDD1 CCDC57 DNAH7 ALMS1 ABI2 NANS ARHGAP12 CGN ARHGAP29 PSMD14 TIMM44 HSPA9 GNL3 WDR62	8.70e-07	853	186	18	28718761
Pubmed	Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.	GSTA1 GSTA2 GSTA3 GSTA5	1.37e-06	16	186	4	8649810
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	RANBP2 POLR2A CUL9 RECQL DICER1 MSH6 GLYR1 CGN DOCK7 EIF5B FH EIF4G3 SF3B2 HSPA9 GNL3	2.67e-06	653	186	15	22586326
Pubmed	Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy.	CYP3A4 HMGCR ABCB1	2.97e-06	6	186	3	20578904
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	RANBP2 MRPL12 POLR2A NEDD1 AHSA1 MSH6 PTPN11 TOX4 ALMS1 EIF5B HTATSF1 PPP1R9B ELF2 EIF4G3 SF3B2 HSPA9 GNL3 WDR62	3.11e-06	934	186	18	33916271
Pubmed	Genetic predictors of interindividual variability in hepatic CYP3A4 expression.	CYP3A4 FOXA3 ABCB1	5.19e-06	7	186	3	19934400
Pubmed	Association between ABCC2 polymorphism and lopinavir accumulation in peripheral blood mononuclear cells of HIV-infected patients.	CYP3A7 CYP3A4 ABCB1	5.19e-06	7	186	3	19842932
Pubmed	PTEN identified as important risk factor of chronic obstructive pulmonary disease.	CYP3A7 HMGCR OPRD1 ABCB1 GSTA4 MSH6 IGF1R BRCA1 ABCB11 IL1RN VCAM1	6.14e-06	374	186	11	19625176
Pubmed	Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway.	CYP3A7 HMGCR OPRD1 ABCB1 GSTA4 MSH6 IGF1R BRCA1 ABCB11 IL1RN VCAM1	7.31e-06	381	186	11	18676680
Pubmed	Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.	CYP3A7 HMGCR OPRD1 ABCB1 GSTA4 MSH6 IGF1R BRCA1 ABCB11 IL1RN VCAM1	7.49e-06	382	186	11	19170196
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	EPHB2 FAT4 EMC3 RECQL HMGCR ZZEF1 PLXNB2 MBOAT2 STT3A ITPR1 ITFG1 IGF1R CELSR3 CELSR2 GLYR1 TMED2 PCOLCE2 UNC93B1 EIF4G3 WDR62	7.64e-06	1201	186	20	35696571
Pubmed	Cyclin M2 (CNNM2) knockout mice show mild hypomagnesaemia and developmental defects.	SLC12A3 TRPV6 TRPV5	8.26e-06	8	186	3	33859252
Pubmed	A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavir.	CYP3A7 CYP3A4 ABCB1	8.26e-06	8	186	3	20147896
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	POLR2A HMGCR NEDD1 DICER1 STT3A STRIP1 CUEDC2 ALMS1 ZMYM1 PRR11 PSMD14 TIMM44 SF3B2 GNL3 WDR62	1.06e-05	733	186	15	34672954
Pubmed	Resveratrol improves health and survival of mice on a high-calorie diet.	GSTA1 GSTA2 GSTA3 GSTA5	1.08e-05	26	186	4	17086191
Pubmed	Identification of genetic variants associated with response to statin therapy.	CYP3A4 HMGCR ABCB1	1.23e-05	9	186	3	19667110
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	RANBP2 RPS6KA3 AHSA1 TOX4 GSPT2 AP1M1 ELAVL4 FH EIF4G3 PYCR2 PSMD14 HNRNPLL HSPA9 GNL3	1.54e-05	665	186	14	30457570
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	EMC3 MRPL12 RALGAPB PLXNB2 DICER1 STT3A ITPR1 GLYR1 SIK2 EIF5B HTATSF1 TMED2 PRR11 EIF4G3 PYCR2 NME4 TIMM44 SF3B2 HSPA9 GNL3 WDR62 NPAT	1.66e-05	1487	186	22	33957083
Pubmed	A Large-scale genetic association study of esophageal adenocarcinoma risk.	CYP3A4 ABCB1 GSTA2 MSH6 PTPN11 IGF1R BRCA1 ABCB11 IL1RN CDK6	2.15e-05	351	186	10	20453000
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RANBP2 POLR2A RECQL HMGCL AHSA1 DICER1 STT3A MSH6 PTPN11 GLYR1 DOCK7 EIF5B AP1M1 FH PYCR2 PSMD14 TIMM44 HNRNPLL SF3B2 HSPA9 GNL3	2.77e-05	1425	186	21	30948266
Pubmed	Impact of lactobacilli on orally acquired listeriosis.	CYP3A4 FABP4 GSTA1 GSTA2 GSTA3 GBP5 GSTA5	2.83e-05	162	186	7	23012479
Pubmed	Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution.	CLTCL1 CUL9 BPIFB6 AIFM3 DOCK6	2.84e-05	66	186	5	15790807
Pubmed	Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients.	CYP3A4 HMGCR ABCB1 CELSR2 ACSM2B	2.84e-05	66	186	5	20679960
Pubmed	Digging Deeper into CYP3A Testosterone Metabolism: Kinetic, Regioselectivity, and Stereoselectivity Differences between CYP3A4/5 and CYP3A7.	CYP3A7 CYP3A4	2.84e-05	2	186	2	28986474
Pubmed	Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin-Induced CYP3A4 and MDR1 Gene Expression.	CYP3A4 ABCB1	2.84e-05	2	186	2	30622215
Pubmed	Influence of genetic variation in CYP3A4 and ABCB1 on dose decrease or switching during simvastatin and atorvastatin therapy.	CYP3A4 ABCB1	2.84e-05	2	186	2	19802823
Pubmed	Alteration of calcium homeostasis in primary preeclamptic syncytiotrophoblasts: effect on calcium exchange in placenta.	TRPV6 TRPV5	2.84e-05	2	186	2	20178461
Pubmed	The TRPV5/6 calcium channels contain multiple calmodulin binding sites with differential binding properties.	TRPV6 TRPV5	2.84e-05	2	186	2	22354706
Pubmed	Diverse calcium channel types are present in the human placental syncytiotrophoblast basal membrane.	TRPV6 TRPV5	2.84e-05	2	186	2	16564089
Pubmed	Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells.	TRPV6 TRPV5	2.84e-05	2	186	2	19295174
Pubmed	Human TRPV5 and TRPV6: key players in cadmium and zinc toxicity.	TRPV6 TRPV5	2.84e-05	2	186	2	23968883
Pubmed	Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients.	CYP3A4 ABCB1	2.84e-05	2	186	2	25240575
Pubmed	ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy.	ABCB1 ABCB11	2.84e-05	2	186	2	25661339
Pubmed	Nucleotide sequence of the human liver glutathione S-transferase subunit 1 cDNA.	GSTA1 GSTA2	2.84e-05	2	186	2	3678589
Pubmed	Identification of cDNAs encoding two human alpha class glutathione transferases (GSTA3 and GSTA4) and the heterologous expression of GSTA4-4.	GSTA3 GSTA4	2.84e-05	2	186	2	9480897
Pubmed	TRPV5 and TRPV6 are expressed in placenta and bone tissues during pregnancy in mice.	TRPV6 TRPV5	2.84e-05	2	186	2	30916584
Pubmed	Down-regulation of glutatione S-transferase α 4 (hGSTA4) in the muscle of thermally injured patients is indicative of susceptibility to bacterial infection.	GSTA1 GSTA4	2.84e-05	2	186	2	22038048
Pubmed	Chromosomal localization of Celsr2 and Celsr3 in the mouse; Celsr3 is a candidate for the tippy (tip) lethal mutant on chromosome 9.	CELSR3 CELSR2	2.84e-05	2	186	2	10790539
Pubmed	Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: generation and analysis of mGsta4 null mouse.	GSTA1 GSTA4	2.84e-05	2	186	2	14761685
Pubmed	Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form.	GSTA1 GSTA2	2.84e-05	2	186	2	15128049
Pubmed	Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression.	GSTA1 GSTA2	2.84e-05	2	186	2	11692074
Pubmed	A single amino acid mutation results in a rapid inactivation of epithelial calcium channels.	TRPV6 TRPV5	2.84e-05	2	186	2	11846401
Pubmed	Structural basis for featuring of steroid isomerase activity in alpha class glutathione transferases.	GSTA2 GSTA3	2.84e-05	2	186	2	20083122
Pubmed	Expression and prognostic roles of TRPV5 and TRPV6 in non-small cell lung cancer after curative resection.	TRPV6 TRPV5	2.84e-05	2	186	2	24761864
Pubmed	Fast and slow inactivation kinetics of the Ca2+ channels ECaC1 and ECaC2 (TRPV5 and TRPV6). Role of the intracellular loop located between transmembrane segments 2 and 3.	TRPV6 TRPV5	2.84e-05	2	186	2	12077127
Pubmed	An isoform of GTPase regulator DOCK4 localizes to the stereocilia in the inner ear and binds to harmonin (USH1C).	DOCK4 USH1C	2.84e-05	2	186	2	16464467
Pubmed	Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors.	CYP3A7 CYP3A4	2.84e-05	2	186	2	25689036
Pubmed	Immunohistochemical markers of CYP3A4 and CYP3A7: a new tool towards personalized pharmacotherapy of hepatocellular carcinoma.	CYP3A7 CYP3A4	2.84e-05	2	186	2	27349315
Pubmed	[The functional characteristics oF TRPV5 and TRPV6 channels in normal and transformed human blood lymphocytes].	TRPV6 TRPV5	2.84e-05	2	186	2	24592736
Pubmed	Lack of an effect of CYP3A4 and MDR1 gene polymorphisms on colchicine pharmacogenetics in the treatment of Familial Mediterranean fever.	CYP3A4 ABCB1	2.84e-05	2	186	2	23408444
Pubmed	MDR1 and CYP3A4 polymorphisms are associated with HIV seropositivity in Israeli patients but do not influence the course of HIV disease.	CYP3A4 ABCB1	2.84e-05	2	186	2	17919092
Pubmed	Incidence of genetic polymorphisms involved in lipid metabolism among Chinese patients with osteonecrosis of the femoral head.	CYP3A4 ABCB1	2.84e-05	2	186	2	19626470
Pubmed	Structural conservation of the genes encoding CaT1, CaT2, and related cation channels.	TRPV6 TRPV5	2.84e-05	2	186	2	11549322
Pubmed	[TRPV5 and TRPV6 calcium channels in human T cells].	TRPV6 TRPV5	2.84e-05	2	186	2	19140341
Pubmed	Differential effects of the enantiomers of tamsulosin and tolterodine on P-glycoprotein and cytochrome P450 3A4.	CYP3A4 ABCB1	2.84e-05	2	186	2	27678410
Pubmed	Effect of Multidrug-Resistant 1 (MDR1) and CYP3A4*1B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients.	CYP3A4 ABCB1	2.84e-05	2	186	2	30799432
Pubmed	Genetic variation and haplotype structures of the glutathione S-transferase genes GSTA1 and GSTA2 in Japanese colorectal cancer patients.	GSTA1 GSTA2	2.84e-05	2	186	2	21844655
Interaction	GSTA2 interactions	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.42e-08	10	183	5	int:GSTA2
Interaction	GSTA5 interactions	GSTA1 GSTA2 GSTA4 GSTA5	8.00e-07	9	183	4	int:GSTA5
Interaction	GSTA1 interactions	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.36e-06	22	183	5	int:GSTA1
Interaction	GSTA4 interactions	GSTA1 GSTA2 GSTA4 GSTA5	3.08e-06	12	183	4	int:GSTA4
Interaction	GSTA3 interactions	GSTA1 GSTA2 GSTA3	7.27e-06	5	183	3	int:GSTA3
Interaction	ZBBX interactions	FAT4 FAT3 ZZEF1 CELSR2 WDR62	8.20e-06	31	183	5	int:ZBBX
Interaction	RPS14P3 interactions	FAT4 CLTCL1 FAT3 CELSR2	8.31e-06	15	183	4	int:RPS14P3
Interaction	DCANP1 interactions	FAT4 FAT3 CELSR3 CELSR2	2.29e-05	19	183	4	int:DCANP1
Interaction	XAGE1A interactions	FAT4 FAT3 CELSR3 CELSR2 ZMYM1	3.36e-05	41	183	5	int:XAGE1A
Interaction	C2CD4B interactions	FAT4 FAT3 PLXNB2 DICER1 CELSR2	4.76e-05	44	183	5	int:C2CD4B
Cytoband	6p12.1	GSTA1 GSTA2 GSTA3 GSTA4	9.74e-06	33	186	4	6p12.1
Cytoband	Ensembl 112 genes in cytogenetic band chr6p12	RHAG GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.64e-05	142	186	6	chr6p12
Cytoband	16p12.3	ACSM5 ACSM2A ACSM2B	3.57e-04	34	186	3	16p12.3
Cytoband	1p36.1-p35	EPHB2 HMGCL	5.77e-04	9	186	2	1p36.1-p35
GeneFamily	Glutathione S-transferases	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	6.14e-07	25	122	5	567
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR3 CELSR2	1.35e-04	3	122	2	913
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR3 CELSR2	1.35e-04	3	122	2	1189
GeneFamily	Acyl-CoA synthetase family	ACSM5 ACSM2A ACSM2B	6.96e-04	26	122	3	40
GeneFamily	Cytochrome P450 family 3	CYP3A7 CYP3A4	1.23e-03	8	122	2	1002
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	CPAMD8 A2ML1	1.58e-03	9	122	2	1234
GeneFamily	ATP binding cassette subfamily B	ABCB1 ABCB11	2.39e-03	11	122	2	806
GeneFamily	Mitogen-activated protein kinase-activated protein kinases	RPS6KA3 RPS6KA6	2.39e-03	11	122	2	1156
GeneFamily	EF-hand domain containing	SCGN EFHB ZZEF1 DNAH7 RYR3 TNNC2	3.72e-03	219	122	6	863
Coexpression	TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN	GSTA1 GSTA2 GSTA3 MPP4 GSTA5	5.83e-07	24	182	5	MM708
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	EPHB2 DOCK4 RANBP2 BAZ2B RPS6KA3 ZZEF1 MBOAT2 DICER1 ITPR1 MSH6 IGF1R PSME4 KLF10 BRCA1 LRIG1 ARHGAP12 ARHGAP29 EIF4G3 NPAT	8.76e-06	856	182	19	M4500
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	OPN3 GSTA1 GSTA2 GSTA3 GSTA5	1.33e-05	44	182	5	MM485
Coexpression	GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN	FCHO2 DICER1 STRIP1 ITPR1 SLC6A11 LRIG1 AP3M2 TRPV6	1.47e-05	157	182	8	M7733
Coexpression	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	CYP3A7 CYP3A4 HMGCR GSTA1 ABCB1 ABCB11	1.51e-05	76	182	6	M9206
Coexpression	WENG_POR_TARGETS_GLOBAL_UP	GSTA1 GSTA2 GSTA3 GSTA5	2.14e-05	24	182	4	MM1190
Coexpression	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP	DENND5B FILIP1 ATP6V0C MFSD4A MBOAT2 STT3A ABCB1 IGF1R RHOBTB1 HNRNPLL	3.46e-05	287	182	10	M6510
Coexpression	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP	DENND5B FILIP1 ATP6V0C MFSD4A MBOAT2 STT3A ABCB1 IGF1R RHOBTB1 HNRNPLL	4.62e-05	297	182	10	MM1003
Coexpression	WENG_POR_DOSAGE	GSTA1 GSTA2 GSTA3 GSTA5	5.35e-05	30	182	4	MM1199
CoexpressionAtlas	kidney_e15.5_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	DENND5B FABP4 SEMA3D PIEZO2 ARHGAP29 VCAM1	1.76e-05	64	181	6	gudmap_kidney_e15.5_Podocyte_MafB_k1_1000
ToppCell	PCW_13-14\|World / Celltypes from embryonic and fetal-stage human lung	DOCK4 FILIP1 FAT3 ABCA8 SEMA3D PIEZO2 IGF1R CD22 VCAM1	1.12e-07	190	186	9	62a3ec1ae0829602b0569cc051210551644f1d46
ToppCell	10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FILIP1 FAT4 FABP4 PIEZO2 ARHGAP29 DOCK6 IL33 VCAM1 ACSM2B	1.17e-07	191	186	9	dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FAT3 NEB SLC6A11 BUB1 AIFM3 ABCB11 DNAH9 ACSM2B	4.21e-07	162	186	8	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 NRCAM FAT3 NEB RYR3 PIEZO2 ELAVL4 DNAH9	1.10e-06	184	186	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 NRCAM FAT3 NEB RYR3 PIEZO2 ELAVL4 DNAH9	1.10e-06	184	186	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 NRCAM FAT3 NEB RYR3 PIEZO2 ELAVL4 DNAH9	1.10e-06	184	186	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	10x5'v1-week_17-19-Endothelial\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FILIP1 FAT4 FABP4 PIEZO2 ARHGAP29 IL33 VCAM1 ACSM2B	1.64e-06	194	186	8	e141beafc9252e5d8c949252bfab53e127c881dc
ToppCell	10x5'v1-week_17-19-Endothelial-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FILIP1 FAT4 FABP4 PIEZO2 ARHGAP29 IL33 VCAM1 ACSM2B	1.64e-06	194	186	8	953578102ffc7b612ee8fce45e414750800fef5d
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM FAT3 SCGN USH1C CELSR3 LRRC53 ELAVL4 SLC29A4	1.77e-06	196	186	8	95544097577f20ed7f4144bd940471cde0617554
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SLC2A7 SEMA3D PIEZO2 ARHGAP29 ACSM5 DOCK6 ACSM2A ACSM2B	1.91e-06	198	186	8	306e28d31fd587409a12dcccc6b2abd7dc9c2e0a
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SLC2A7 SEMA3D PIEZO2 ARHGAP29 ACSM5 DOCK6 ACSM2A ACSM2B	1.91e-06	198	186	8	05429f18e1d74880c1835568c86177f661b3477a
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	FAT4 BAZ2B MFSD4A PTPRG DIAPH2 ARHGAP29 DOCK6 IL33	2.06e-06	200	186	8	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	DIS3L2 DNAH7 DICER1 TOX4 MTHFD2L PYCR2 ACSM2B	6.17e-06	165	186	7	242bdb7654f415391fb8e9bdc06412c7eee9c97e
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	DIS3L2 DNAH7 DICER1 TOX4 MTHFD2L PYCR2 ACSM2B	6.17e-06	165	186	7	436ce4bc75e1ba4351c439ccad19f84ad5bcb92f
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell\|E16.5-samps / Age Group, Lineage, Cell class and subclass	FOXA3 GSTA4 BRCA1 CELSR2 CGN RPS6KA6 CDH16	7.51e-06	170	186	7	5a64e05c263df915085988d881808221e2c0f2e2
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CPAMD8 FAT4 ABCB1 PTPRG ARHGAP29 DOCK6 IL33	7.80e-06	171	186	7	1597459c971d6befa991d59dc66b41b6a522f797
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Itih5\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	BPIFB6 SCGN GRID2IP RPS6KA6 SLC29A4 ACSM2B	9.37e-06	116	186	6	605bd4fdf547cc41783e99cd78425760ef6461ef
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 RANBP2 RPS6KA3 FCHO2 GBP5 DIAPH2 ARHGAP29	1.01e-05	178	186	7	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAT4 ABCB1 LCNL1 ARHGAP29 OR3A3 IL33 VCAM1	1.09e-05	180	186	7	27e8bbee388e64dd79d70b160b76d45b1f398006
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	USH1C SLC22A12 ABCB1 RHOBTB1 ACSM2A VCAM1 ACSM2B	1.09e-05	180	186	7	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	droplet-Kidney-nan-18m-Epithelial-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MFSD4A GSTA2 GSTA4 SLC12A3 HSPA9 CDH16 ACSM2B	1.09e-05	180	186	7	cd743f81838ba210e5bb63fe0870918d7d2b0112
ToppCell	Epithelial-lung_neuroendocrine_cell_(PNEC)\|World / Lineage, Cell type, age group and donor	PCSK2 NRCAM SCGN USH1C OPRD1 ELAVL4 SLC29A4	1.17e-05	182	186	7	57bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MFSD4A ITPR1 SLC12A3 DOCK7 TRPV6 TRPV5 CDH16	1.21e-05	183	186	7	2f0ee40e69ad1259e56e8ee4b352736900eb8901
ToppCell	ILEUM-inflamed-(7)_Lymphatics\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FILIP1 OVOS2 SEMA3D PIEZO2 ARHGAP29 IL33 ACSM2B	1.30e-05	185	186	7	d711dd2e91cfee723dae1ccb2b910b8cf3becc3b
ToppCell	5'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPHB2 MLXIP LRRC53 AIFM3 NME4 QTRT1 CDK6	1.30e-05	185	186	7	655a9357a7711cefb48395e0b2a5a0ab90bcf3f5
ToppCell	(4)_Lymph_vessel\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	OVOS2 FABP4 SEMA3D PIEZO2 ARHGAP29 ACSM5 ACSM2A	1.35e-05	186	186	7	6b3afc2ae870ff73e30a60ce84fcee0eb365d809
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAT4 ABCB1 LCNL1 PTPRG ARHGAP29 IL33 VCAM1	1.40e-05	187	186	7	e35716f8b482be3bf5ab79f087a9caf67a9d197a
ToppCell	Monocytes-M2-like_CD16+_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	BAZ2B FCHO2 NEB RHOBTB1 ARHGAP12 ACSM5 VCAM1	1.40e-05	187	186	7	59e31c51183ed4c9a3d0792c8005ea3a12b28dfa
ToppCell	15-Distal-RBC\|Distal / Age, Tissue, Lineage and Cell class	CYP3A7 RHAG GSTA1 GSTA2 ACSM2A SERPIND1 ACSM2B	1.44e-05	188	186	7	c68ccb1c5c21d13ddac09b16e7d466f0530bbda5
ToppCell	15-Distal-RBC-RBC\|Distal / Age, Tissue, Lineage and Cell class	CYP3A7 RHAG GSTA1 GSTA2 ACSM2A SERPIND1 ACSM2B	1.44e-05	188	186	7	2534684e4932c1255c24a26ca2277ac7af0a118b
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FILIP1 USH1C CCIN OPRD1 SEMA3D GBP5	1.50e-05	126	186	6	28fbe63f7bc628b32d8e86bf9e80657e776dd1cc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 OPN3 RYR3 MMP7 ACSM2A CTSV VCAM1	1.65e-05	192	186	7	b18ae7337eaad1315a5b0ee81c75f7606bd3c7fe
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 OPN3 RYR3 MMP7 ACSM2A CTSV VCAM1	1.65e-05	192	186	7	b2d9cc2a013012b25b458d4dc77be63e1c2144da
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK4 FAT4 BAZ2B MFSD4A ABCB1 PIEZO2 IL33	1.71e-05	193	186	7	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT3 SCGN USH1C OPRD1 CELSR3 ELAVL4 SLC29A4	1.77e-05	194	186	7	2dcc3b99dbedaf8a6916891c85091ddb79d7ee31
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SCGN USH1C ABCB1 MMP7 ACSM2A VCAM1 ACSM2B	1.77e-05	194	186	7	70185c0b8e0f4e896645b17a243482ba3cdf4a5d
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 BAZ2B MFSD4A IGF1R PTPRG ARHGAP29 DOCK6	1.77e-05	194	186	7	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK2 NRCAM ABCA8 CUEDC2 INSC ARHGAP29 ELAVL4	1.83e-05	195	186	7	9fea1ddb68da83ca43dd8006c9e51295b1817f0e
ToppCell	NS-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FILIP1 EFHB DNAH7 GSTA1 GSTA2 DNAH9 MAP3K19	1.83e-05	195	186	7	34e37cff4849696ca4ba5dd8fd2cf98fed8bc912
ToppCell	BL-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FILIP1 EFHB DNAH7 GSTA1 GSTA2 DNAH9 MAP3K19	1.83e-05	195	186	7	07a6bcef6af93ed87df455dee624037cb75e011a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FILIP1 FAT4 FAT3 ABCA8 SEMA3D PIEZO2 VCAM1	1.83e-05	195	186	7	1cdf5f296029ae424d9dba42e86a6d111e4896e6
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK2 NRCAM ABCA8 CUEDC2 INSC ARHGAP29 ELAVL4	1.89e-05	196	186	7	9afd0a7135028a446f06bb68f334e79b8f171b45
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DOCK4 FILIP1 FAT4 FAT3 ABCA8 SEMA3D PIEZO2	1.89e-05	196	186	7	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SCGN USH1C OPRD1 CELSR3 CELSR2 ELAVL4 SLC29A4	1.89e-05	196	186	7	4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725
ToppCell	Skin-Tubules\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	DENND5B NRCAM MFSD4A DNAH7 GSTA2 SLC12A3 CDH16	1.89e-05	196	186	7	12e21cc310a261407b46e034108e8c93ea16e045
ToppCell	PCW_10-12\|World / Celltypes from embryonic and fetal-stage human lung	DOCK4 FILIP1 FAT3 ABCA8 SEMA3D ELF2 VCAM1	1.95e-05	197	186	7	47fd8b0d596c5db1a722473c8efbb17a6bbe7538
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-sinusoidal_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FILIP1 FABP4 PIEZO2 ARHGAP29 DOCK6 IL33 VCAM1	1.95e-05	197	186	7	f1080d93acf1a4756d2f2c8cabd1fb50bc7bcd09
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DOCK4 FILIP1 FAT3 ABCA8 SEMA3D PIEZO2 VCAM1	1.95e-05	197	186	7	31a1852911bda38543916585fda34255fd62a134
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FILIP1 FAT4 FAT3 ABCA8 SEMA3D PIEZO2 PTPRG	1.95e-05	197	186	7	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FILIP1 FAT4 FAT3 ABCA8 SEMA3D PIEZO2 VCAM1	1.95e-05	197	186	7	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	Epithelial_cells-Epithelial_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	USH1C SLC22A12 GSTA1 GSTA2 RHOBTB1 ACSM2A ACSM2B	2.02e-05	198	186	7	52e9d41a1726bc1140df6baec9f17a534448ac8b
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	FILIP1 RANBP2 NLRC4 ITPR1 MSH6 ALMS1 VCAM1	2.02e-05	198	186	7	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GCHFR USH1C SLC22A12 GSTA1 ACSM2A VCAM1 ACSM2B	2.02e-05	198	186	7	72733b6149b797ac11cc108bc80428b77fbbba78
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	FILIP1 RANBP2 NLRC4 ITPR1 MSH6 ALMS1 VCAM1	2.02e-05	198	186	7	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SCGN USH1C RHOBTB1 MMP7 ACSM2A VCAM1 ACSM2B	2.02e-05	198	186	7	be305d89d48c67ce922fa71aaf15e24d00c89ff6
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	FILIP1 RANBP2 NLRC4 ITPR1 MSH6 ALMS1 VCAM1	2.02e-05	198	186	7	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GCHFR USH1C SLC22A12 GSTA1 ACSM2A VCAM1 ACSM2B	2.02e-05	198	186	7	f23559ce6072e3c323f6791ff95269271b0f7ff1
ToppCell	Epithelial_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	USH1C SLC22A12 GSTA1 GSTA2 RHOBTB1 ACSM2A ACSM2B	2.02e-05	198	186	7	eeec789d226171f30799577cc37c07bdced2e3cb
ToppCell	distal-Epithelial-Ciliated-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	EFHB DNAH7 GSTA1 GSTA2 GSTA3 DNAH9 MAP3K19	2.08e-05	199	186	7	2de1fe124737a6cca4b3805ab3056f9d9d7c16c7
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CCNJ USH1C CCDC57 MEPE FOXP4 MTHFD2L MMP7	2.08e-05	199	186	7	121de4e02585de3a3010398387c523bacf8ce546
ToppCell	LPS_anti-TNF-Epithelial_airway\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	DNAH7 MEPE GSTA3 A2ML1 MMP7 DNAH9 MAP3K19	2.08e-05	199	186	7	6aca164bbbb961f34b1e6f1857f91ade5c059405
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Myeloid-Megakaryocyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM CUL9 ITPR1 SEMA3D PIEZO2 CD22 ZNF649	2.08e-05	199	186	7	6e7f7214317f2af2ba8523df9896f54b7294d58a
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Myeloid\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM CUL9 ITPR1 SEMA3D PIEZO2 CD22 ZNF649	2.08e-05	199	186	7	5f499595597c10857bba8272f62afe4d32d733ac
ToppCell	LPS_anti-TNF-Epithelial_airway-airway_epithelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	DNAH7 MEPE GSTA3 A2ML1 MMP7 DNAH9 MAP3K19	2.08e-05	199	186	7	60919c2af31d39a2d36d7bc432e43dab2a4e05fb
ToppCell	PCW_10-12-Mesenchymal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FILIP1 FAT4 FAT3 ABCA8 SEMA3D PIEZO2 PTPRG	2.08e-05	199	186	7	a09292de4c4447b8eee55d401808e43b817321cc
ToppCell	Kidney\|World / Skin and Kidney Cells in Lupus Nephritis Patients.	MFSD4A SLC12A3 MMP7 ACSM2A VCAM1 CDH16 ACSM2B	2.15e-05	200	186	7	1f99afa1f3c32a2a9cfb4ad33ff4d404e34fac63
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GCHFR USH1C SLC22A12 GSTA1 ACSM2A VCAM1 ACSM2B	2.15e-05	200	186	7	234e5a927eec0e235226586451ba3754c8a14169
ToppCell	LPS_IL1RA_TNF-Epithelial_airway\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	EFHB DNAH7 GSTA3 A2ML1 DNAH9 CTSV MAP3K19	2.15e-05	200	186	7	72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FAT4 BAZ2B MFSD4A PTPRG DIAPH2 ARHGAP29 DOCK6	2.15e-05	200	186	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	EFHB DNAH7 GSTA3 A2ML1 DNAH9 CTSV MAP3K19	2.15e-05	200	186	7	da12821e8a0657869ca0f75d351cce2d7605a505
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GCHFR USH1C SLC22A12 GSTA1 ACSM2A VCAM1 ACSM2B	2.15e-05	200	186	7	e118d5e6e5d5bb808877a6667668c36f21afad5b
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FAT4 BAZ2B MFSD4A PTPRG DIAPH2 ARHGAP29 DOCK6	2.15e-05	200	186	7	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	USH1C ABCB1 RHOBTB1 MMP7 ACSM2A VCAM1 ACSM2B	2.15e-05	200	186	7	105564ee05bd11685b5747ee32d5350cf3c2e2e1
ToppCell	droplet-Liver-Npc-21m-Epithelial-Hepatocyte_(Midlobular)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCHFR GSTA2 GSTA3 GSTA4 HEBP1 ACSM5	3.08e-05	143	186	6	0cd332c128710291a39957d3da22953352f5c382
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 DNAH7 MMP7 ACSM2A VCAM1 ACSM2B	4.49e-05	153	186	6	499670e716fc85ce76630fc813cec86f8419f2a1
ToppCell	Club_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	MFSD4A PLXNB2 MBOAT2 GSTA1 GSTA2 CDK6	5.56e-05	159	186	6	a7bcff268b1962a561fd2848e01ae16565bce895
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUL9 MFSD4A NEB RYR3 ABCB1 CGN	5.56e-05	159	186	6	4000ed0d3b7d488722bcd0042fa2ff4405aaab82
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUL9 MFSD4A NEB RYR3 ABCB1 CGN	5.56e-05	159	186	6	7619d0d49738dd08daf01b42664691a5323aa793
ToppCell	PND01-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GSTA1 GSTA2 GSTA3 GSTA4 CGN SERPIND1	5.76e-05	160	186	6	01ae730e9d0d05f3277f862f0c09bafb32b89db5
ToppCell	PND01-Epithelial-Epithelial_Airway-Neurosecretory\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GSTA1 GSTA2 GSTA3 GSTA4 CGN SERPIND1	5.76e-05	160	186	6	6de9e7be1d860d82d503bfbc779e72f072a6efc3
ToppCell	PND01-Epithelial-Epithelial_Airway-Neurosecretory-Secretory\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GSTA1 GSTA2 GSTA3 GSTA4 CGN SERPIND1	5.76e-05	160	186	6	b4844a8c7755a2b2868019791d8d224154973445
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMGCL RYR3 CD22 BUB1 PRR11 WDR62	6.61e-05	164	186	6	4307b002fb41ddfc7ab8a6bca66a60942c250052
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMGCL RYR3 CD22 BUB1 PRR11 WDR62	6.61e-05	164	186	6	1d84aa5b925f502ee9c5fa39714490f613a58028
ToppCell	3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EPHB2 USH1C VPS13D CELSR2 MMP7 IL33	7.06e-05	166	186	6	9fd9de82f98b9acdaa59ac98fb9664161514aec0
ToppCell	droplet-Heart-nan-18m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GSTA1 GSTA3 GSTA4 MSH6 SEMA3D PRR11	7.06e-05	166	186	6	9adceb746e67e955fd8b3e0984f4eed44b64a270
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FILIP1 GSTA1 SEMA3D PIEZO2 ABCB11 PCOLCE2	7.06e-05	166	186	6	739dfbe927f409821ff23aca6e47ebe78f57e859
ToppCell	PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GSTA2 GSTA3 GSTA4 CGN BUB1 PRR11	7.30e-05	167	186	6	a90f905ef38437752e2b0b71bd0322a184de1861
ToppCell	facs-Spleen-nan-24m-Lymphocytic-CD79a_B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK2 POLR2A SCGN GSTA4 CD22 UNC93B1	8.59e-05	172	186	6	0c6332a806ac75fffae6080f61965555c7f687f4
ToppCell	3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPHB2 DOCK4 SEMA3D KCNN1 DOCK6 ACSM2A	8.87e-05	173	186	6	85083b9ce20351dd69aa2327ad087b848b4307ff
ToppCell	Endothelial-B-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	OVOS2 SEMA3D PIEZO2 ARHGAP29 IL33 ACSM2B	8.87e-05	173	186	6	a81992965137195d20fc498f750975303961a828
ToppCell	droplet-Kidney-nan-21m-Epithelial-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCHFR GSTA2 GSTA3 GSTA4 INSC	9.04e-05	108	186	5	7ef144b8039889c8e883b958c50c121bce972e0d
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SCGN OVCH1 OPRD1 CELSR3 MPP4 ELAVL4	9.75e-05	176	186	6	116741fef5895ca85057d2d31eca9eba5764ab44
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SCGN OVCH1 OPRD1 CELSR3 MPP4 ELAVL4	9.75e-05	176	186	6	5b707f58d164ee7a6a527dd5d053472ce9a631c1
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 OPN3 RYR3 MMP7 CTSV VCAM1	1.04e-04	178	186	6	a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell	droplet-Liver-LIVER-NPC-1m-Epithelial-Hepatocyte_(Pericentral)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCHFR GSTA1 GSTA2 GSTA3 GSTA4 HEBP1	1.07e-04	179	186	6	10baf575f06f9a15384bcdc751446b4670acf942
ToppCell	ILEUM-non-inflamed-(7)_Lymphatics\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FILIP1 OVOS2 SEMA3D PIEZO2 ARHGAP29 ACSM2B	1.07e-04	179	186	6	99777a8931356d1206b8ab22aaa1b1d5a600b809
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK2 MFSD4A SCGN SEMA3D DOCK6 SLC29A4	1.10e-04	180	186	6	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYP3A7 NRCAM FAT3 ABCA8 SEMA3D PIEZO2	1.10e-04	180	186	6	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_NK-T_mait\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ANKK1 NCR3LG1 CCIN ABCB1 GBP5 IL23R	1.10e-04	180	186	6	e53e9f3ebd48fb8237515e740ba5d9880ed6ade3
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK2 MFSD4A SCGN SEMA3D DOCK6 SLC29A4	1.10e-04	180	186	6	423454e3390080ae03bb3cbb267255ebfe4df080
Computational	Genes in the cancer module 101.	GSTA2 GSTA3 GSTA4	1.19e-04	10	110	3	MODULE_101
Computational	Genes upregulated in subsets of cells of a given type within various tumors	GCHFR GSTA1 GSTA2 ACSM2A ACSM2B	1.50e-04	50	110	5	GAVISH_3CA_MALIGNANT_METAPROGRAM_38_GLUTATHIONE
Drug	clotrimazole	CYP3A7 CYP3A4 RPS6KA3 HMGCR GSTA1 ABCB1 GSTA2 GSTA3 GSTA4 GSTA5 RPS6KA6 KCNN1	1.93e-09	143	183	12	CID000002812
Drug	aflatoxin B1-2,3-oxide	CYP3A4 GSTA2 GSTA3 GSTA4 GSTA5	7.75e-09	10	183	5	ctd:C006426
Drug	oltipraz	CYP3A4 GSTA1 ABCB1 GSTA2 GSTA3 GSTA4 GSTA5 ABCB11	1.53e-08	56	183	8	ctd:C026209
Drug	AA-GSH	CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.24e-08	23	183	6	CID000083998
Drug	Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	EPHB2 SPEG DNAH7 ITPR1 MSH6 VPS13D TOX4 BRCA1 GLYR1 BUB1 TMED2 SERPIND1	4.47e-08	189	183	12	6717_DN
Drug	quercetin 3-arabinopyranoside	GSTA1 GSTA2 GSTA3 GSTA5	5.98e-08	6	183	4	ctd:C428865
Drug	1,2-dichloro-4-nitrobenzene	GSTA1 GSTA2 GSTA3 GSTA4	5.98e-08	6	183	4	ctd:C028328
Drug	C14802	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	9.26e-08	47	183	7	CID011954053
Drug	C14800	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.08e-07	48	183	7	CID011954051
Drug	bromobenzene-3,4-oxide	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.25e-07	49	183	7	CID000108121
Drug	bromobenzene-2,3-oxide	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.44e-07	50	183	7	CID003036760
Drug	1,1-dichloroethylene epoxide	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.44e-07	50	183	7	CID000119521
Drug	naphthalene epoxide	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.66e-07	51	183	7	CID000108063
Drug	dichloroacetaldehyde	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.49e-07	54	183	7	CID000006576
Drug	Clch2cosg	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.50e-07	18	183	5	CID000163913
Drug	C14791	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.50e-07	18	183	5	CID011954044
Drug	C14793	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.50e-07	18	183	5	CID011954046
Drug	C14803	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.50e-07	18	183	5	CID011954054
Drug	C14805	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.50e-07	18	183	5	CID011954056
Drug	C14804	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.50e-07	18	183	5	CID011954055
Drug	C14806	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.50e-07	18	183	5	CID011954057
Drug	C14848	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.50e-07	18	183	5	CID011954067
Drug	C14856	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.50e-07	18	183	5	CID011954069
Drug	C14855	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.50e-07	18	183	5	CID011954068
Drug	S-(2,2-dichloro-1-hydroxy)ethylglutathione	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.50e-07	18	183	5	CID011954070
Drug	AC1L4MYY	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.50e-07	18	183	5	CID000188517
Drug	kahweol palmitate	GSTA1 GSTA2 GSTA3 GSTA4	2.76e-07	8	183	4	ctd:C033997
Drug	chloroacetyl chloride	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.83e-07	55	183	7	CID000006577
Drug	bromoacetaldehyde	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	4.11e-07	58	183	7	CID000105131
Drug	CID5475388	CYP3A7 CYP3A4 GSTA1 GSTA3 GSTA5	4.46e-07	20	183	5	CID005475388
Drug	2-(S-glutathionyl) acetyl glutathione	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	4.46e-07	20	183	5	CID011954072
Drug	C14865	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	4.46e-07	20	183	5	CID011954073
Drug	cafestol	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	5.82e-07	21	183	5	ctd:C053400
Drug	BP-4,5-oxide	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	5.84e-07	61	183	7	CID000037786
Drug	angelica lactone	GSTA1 GSTA2 GSTA3 GSTA4	8.17e-07	10	183	4	ctd:C019257
Drug	aminotriazole	CYP3A7 CYP3A4 GSTA1 ABCB1 GSTA2 GSTA3 GSTA4 GSTA5 TRPV6 TRPV5	1.05e-06	167	183	10	CID000001639
Drug	S-(formylmethyl)glutathione	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.19e-06	24	183	5	CID011954074
Drug	PCB 77	ATP6V0C CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.27e-06	98	183	8	CID000036187
Drug	Troleandomycin	CYP3A7 CYP3A4 ABCB1 GSTA2	1.28e-06	11	183	4	ctd:D014217
Drug	chlorpyrifos	CYP3A7 CYP3A4 GSTA1 ABCB1 GSTA2 GSTA3 GSTA4 GSTA5	1.60e-06	101	183	8	CID000002730
Drug	1,2-dibromoethane	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.66e-06	71	183	7	CID000007839
Drug	benzotriazole	GSTA2 GSTA3 GSTA5	2.03e-06	4	183	3	ctd:C012771
Drug	Cholic Acid	CYP3A4 GSTA1 ABCB1 GSTA2 GSTA3 GSTA4 ABCB11	2.42e-06	75	183	7	ctd:D019826
Drug	hypericin	CYP3A7 CYP3A4 GSTA1 ABCB1 GSTA2 GSTA3 GSTA4 GSTA5	2.65e-06	108	183	8	CID005281051
Drug	AC1Q608X	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.69e-06	28	183	5	CID000128466
Drug	AC1L33DC	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.69e-06	28	183	5	CID000133757
Drug	phenanthroline	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5 MMP7	2.94e-06	50	183	6	CID000067473
Drug	CAS 81-11-8	GSTA1 GSTA2 GSTA3 GSTA4 NANS GSTA5 SF3B2 VCAM1	3.05e-06	110	183	8	CID000006668
Drug	BP-7,8-diol	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	3.15e-06	78	183	7	CID000025892
Drug	2-BHA	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	3.22e-06	29	183	5	CID000006932
Drug	PCB 126	ATP6V0C GSTA1 GSTA2 GSTA3 GSTA4 GSTA5 VCAM1	3.74e-06	80	183	7	CID000063090
Drug	indole-3-carbinol	CYP3A4 GSTA1 ABCB1 GSTA2 GSTA3 GSTA4 BRCA1 GSTA5 CDK6	4.47e-06	154	183	9	CID000003712
Drug	Dcvg	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	4.55e-06	31	183	5	CID006437359
Drug	o-dinitrobenzene	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	4.55e-06	31	183	5	CID000010707
Drug	AC1L1G85	HMGCR OPRD1 ABCB1 RPIA DIAPH2 IL1RN	4.66e-06	54	183	6	CID000003569
Drug	Benzoxazoles	GSTA2 GSTA3 GSTA5	5.05e-06	5	183	3	ctd:D001583
Drug	Selenium Compounds	GSTA2 GSTA3 GSTA5	5.05e-06	5	183	3	ctd:D018036
Drug	trichloroethylene	CYP3A7 CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	7.09e-06	88	183	7	CID000006575
Drug	perhexiline	CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	7.11e-06	58	183	6	CID000004746
Drug	m-toluidine	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	7.31e-06	34	183	5	CID000007934
Drug	Lyndiol	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	7.31e-06	34	183	5	CID000082149
Drug	dimethoxystrychnine	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	8.48e-06	35	183	5	CID000009649
Drug	Dixan	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	8.48e-06	35	183	5	CID000010404
Drug	NAPQI	CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	9.56e-06	61	183	6	CID000039763
Drug	PenCB	ATP6V0C GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	9.56e-06	61	183	6	CID000036188
Drug	Glutathione	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	9.78e-06	36	183	5	DB00143
Drug	2-allylphenol	GSTA1 GSTA2 GSTA3	1.00e-05	6	183	3	ctd:C099328
Drug	isosafrole	CYP3A4 ABCB1 GSTA2	1.00e-05	6	183	3	ctd:C015959
Drug	1-cyano-2-hydroxy-3-butene	GSTA2 GSTA3 GSTA5	1.00e-05	6	183	3	ctd:C055903
Drug	isomethyleugenol	GSTA1 GSTA2 GSTA3	1.00e-05	6	183	3	ctd:C031050
Drug	DB 203	CYP3A4 STT3A ABCB1	1.00e-05	6	183	3	CID000459917
Drug	Gsts	CYP3A7 CYP3A4 GSTA1 ABCB1 GSTA2 GSTA3 GSTA4 GSTA5 AP1M1	1.15e-05	173	183	9	CID000128079
Drug	Bilirubin	CYP3A4 HMGCR GSTA1 GSTA2 GSTA3 GSTA4 FAM174A ARHGAP29 ABCB11	1.32e-05	176	183	9	ctd:D001663
Drug	pioglitazone	CYP3A7 CYP3A4 SLC2A7 INSRR FOXA3 FABP4 RYR3 ITPR1 PTPN11 ABCB11 MMP7 VCAM1	1.39e-05	326	183	12	CID000004829
Drug	Clotrimazole	CYP3A7 CYP3A4 GSTA1 ABCB1 GSTA2 ABCB11	1.51e-05	66	183	6	ctd:D003022
Drug	AC1NSK22	RYR3 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.51e-05	66	183	6	CID005311131
Drug	Ethoxyquin	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	1.66e-05	40	183	5	ctd:D005015
Drug	amprenavir	CYP3A4 ABCB1 ABCB11	1.75e-05	7	183	3	ctd:C095108
Drug	lovastatin acid	CYP3A4 HMGCR ABCB1 ABCB11	1.77e-05	20	183	4	CID000064727
Drug	sulfobromophthalein	GSTA1 ABCB1 GSTA2 GSTA3 GSTA4 GSTA5 ABCB11	2.00e-05	103	183	7	CID000005345
Drug	loperamide	CYP3A4 RYR3 OPRD1 ABCB1 ITPR1 CGN TRPV6	2.27e-05	105	183	7	CID000003954
Drug	benzyl isothiocyanate	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5 MMP7	2.31e-05	71	183	6	CID000002346
Drug	Lithocholic Acid	CYP3A4 HMGCR GSTA1 ABCB1 GSTA2 GSTA3 GSTA4 ABCB11 TRPV6 VCAM1	2.58e-05	240	183	10	ctd:D008095
Drug	phenobarbital quinidine	CYP3A4 GSTA1 GSTA2 SLC6A11	2.64e-05	22	183	4	ctd:C033457
Drug	CAS 87-33-2	CYP3A4 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	2.71e-05	73	183	6	CID000003780
Drug	Fusidic Acid	CYP3A4 ABCB1 ABCB11	2.78e-05	8	183	3	ctd:D005672
Drug	hypericin	CYP3A4 GSTA1 ABCB1	2.78e-05	8	183	3	ctd:C004965
Drug	Hydroxy Itraconazole	CYP3A4 HMGCR ABCB1	2.78e-05	8	183	3	CID000108222
Drug	Selenocysteine	GSTA2 GSTA3 GSTA5	2.78e-05	8	183	3	ctd:D017279
Drug	Glucosinolates	GSTA1 GSTA2 GSTA3	2.78e-05	8	183	3	ctd:D005961
Drug	triethyllead	GSTA1 GSTA2 GSTA3	2.78e-05	8	183	3	ctd:C010360
Drug	amodiaquine quinoneimine	CYP3A4 GSTA2 GSTA4	2.78e-05	8	183	3	ctd:C094705
Drug	Fursultiamine Hydrochloride [2105-43-3]; Down 200; 9.2uM; HL60; HT_HG-U133A	PTPN11 TOX4 ALMS1 ABI2 BUB1 MTHFD2L QTRT1 IL1RN NPAT	2.97e-05	195	183	9	2929_DN
Drug	CAY10397; Down 200; 10uM; PC3; HT_HG-U133A	RECQL DICER1 IGF1R CELSR2 BUB1 RPS6KA6 TMED2 FH QTRT1	3.10e-05	196	183	9	7087_DN
Drug	CoCl2	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5 VCAM1	3.16e-05	75	183	6	CID003015678
Drug	2,4,6-trinitrotoluene	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5 TNNC2	3.16e-05	75	183	6	CID000008376
Drug	zeta-1-tocopherol	CYP3A4 HMGCR ABCB1 VCAM1	3.17e-05	23	183	4	CID000092161
Drug	4-hydroxyanisole	GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	3.33e-05	46	183	5	CID000009015
Drug	tocotrienol, delta	CYP3A4 ABCB1 PSME4 MMP7 IL1RN VCAM1	3.41e-05	76	183	6	ctd:C082097
Drug	beta-naphthoflavone	ATP6V0C CYP3A7 CYP3A4 AHSA1 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5	3.63e-05	200	183	9	CID000002361
Disease	X-11478 measurement	ACSM5 ACSM2A ACSM2B	2.09e-07	3	176	3	EFO_0021242
Disease	indoleacetoylcarnitine measurement	ACSM5 ACSM2A ACSM2B	4.12e-06	6	176	3	EFO_0800106
Disease	3-Indolepropionic acid measurement	ACSM5 ACSM2B	3.54e-05	2	176	2	EFO_0021560
Disease	X-21319 measurement	ACSM2A ACSM2B	3.54e-05	2	176	2	EFO_0800807
Disease	amino acid measurement	EPHB2 FAT4 CLTCL1 SLC2A7 MLXIP DNAH7 RYR3 ALMS1 PTPRG LRIG1 SHPRH AIFM3 CTSV HNRNPLL	6.06e-05	678	176	14	EFO_0005134
Disease	Hypotension, Orthostatic	OPRD1 ABCB1	1.06e-04	3	176	2	C0020651
Disease	ulcerative colitis (is_implicated_in)	ABCB1 IL1RN IL23R	1.33e-04	17	176	3	DOID:8577 (is_implicated_in)
Disease	high grade glioma (implicated_via_orthology)	INSRR ABCB1 IGF1R WDR62	1.38e-04	44	176	4	DOID:3070 (implicated_via_orthology)
Disease	polyunsaturated fatty acid measurement	HMGCR PTPN11 CELSR2 DOCK7 ABCB11 DOCK6	1.40e-04	131	176	6	EFO_0010733
Disease	level of Phosphatidylinositol (18:0_18:1) in blood serum	DOCK7 PCOLCE2 DOCK6	1.59e-04	18	176	3	OBA_2045155
Disease	etiocholanolone glucuronide measurement	CYP3A7 CYP3A4 NLRC4	1.88e-04	19	176	3	EFO_0800362
Disease	total lipids in lipoprotein particles measurement	HMGCR CELSR2 DOCK7 DOCK6	1.94e-04	48	176	4	EFO_0022309
Disease	lipid measurement, lipoprotein measurement	HMGCR PTPN11 CELSR2 DOCK7 DOCK6	2.08e-04	90	176	5	EFO_0004529, EFO_0004732
Disease	apolipoprotein B to apolipoprotein A1 ratio	HMGCR ABCA8 CELSR2 DOCK6	2.10e-04	49	176	4	EFO_0021897
Disease	Coffin-Lowry syndrome (implicated_via_orthology)	RPS6KA3 RPS6KA6	2.11e-04	4	176	2	DOID:3783 (implicated_via_orthology)
Disease	tacrolimus measurement	CYP3A7 CYP3A4	2.11e-04	4	176	2	EFO_0008458
Disease	estrone conjugate measurement	CYP3A7 CYP3A4	2.11e-04	4	176	2	EFO_0007971
Disease	Autosomal Recessive Primary Microcephaly	PYCR2 WDR62 CDK6	2.96e-04	22	176	3	C3711387
Disease	tauro-beta-muricholate measurement	CYP3A7 CYP3A4	3.50e-04	5	176	2	EFO_0800213
Disease	glyco-beta-muricholate measurement	CYP3A7 CYP3A4	3.50e-04	5	176	2	EFO_0800569
Disease	3-hydroxyhexanoate measurement	ACSM2A ACSM2B	3.50e-04	5	176	2	EFO_0800378
Disease	Parkinson's disease (implicated_via_orthology)	INSRR OPRD1 IGF1R SLC17A8 EIF4G3 HSPA9	3.71e-04	157	176	6	DOID:14330 (implicated_via_orthology)
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	HMGCR SCGN FOXA3 ABCA8 CELSR2 DOCK7 ABCB11 DOCK6	4.94e-04	303	176	8	EFO_0004612, EFO_0020945
Disease	dehydroisoandrosterone sulfate DHEA-S measurement	CYP3A7 CYP3A4	5.22e-04	6	176	2	EFO_0021119
Disease	Adult only	MSH6 BRCA1	5.22e-04	6	176	2	C3842001
Disease	androstenediol (3beta,17beta) monosulfate (1) measurement	CYP3A7 CYP3A4	5.22e-04	6	176	2	EFO_0800294
Disease	toxic encephalopathy (is_implicated_in)	ABCB1 IGF1R	5.22e-04	6	176	2	DOID:3602 (is_implicated_in)
Disease	X-24574 measurement	CYP3A7 CYP3A4	7.28e-04	7	176	2	EFO_0800897
Disease	Breast Cancer, Familial	RECQL MSH6 BRCA1	7.52e-04	30	176	3	C0346153
Disease	cholesterol to total lipids in very large HDL percentage	CELSR2 DOCK7 DOCK6	8.29e-04	31	176	3	EFO_0022243
Disease	linoleic acid measurement	HMGCR PTPN11 CELSR2 DOCK7 ABCB11 DOCK6	9.05e-04	186	176	6	EFO_0006807
Disease	Cholestasis of pregnancy	ABCB11 VCAM1	9.67e-04	8	176	2	C0268318
Disease	X-17676 measurement	ACSM5 ACSM2B	9.67e-04	8	176	2	EFO_0800785
Disease	Liver carcinoma	RPS6KA3 HMGCR ABCB1 IGF1R CELSR3 BUB1 IL1RN HSPA9 VCAM1 WDR62	9.84e-04	507	176	10	C2239176
Disease	hyperuricemia	SLC22A12 IGF1R LRIG1	9.98e-04	33	176	3	EFO_0009104
Disease	esterified cholesterol measurement	HMGCR FOXA3 CELSR2 DOCK7 DOCK6	1.04e-03	128	176	5	EFO_0008589
Disease	omega-6 polyunsaturated fatty acid measurement	HMGCR CELSR2 DOCK7 ABCB11 DOCK6 IL23R	1.22e-03	197	176	6	EFO_0005680
Disease	BMI-adjusted waist-hip ratio, adult onset asthma	FOXA3 SIK2	1.24e-03	9	176	2	EFO_0007788, EFO_1002011
Disease	cystic fibrosis (implicated_via_orthology)	ABCB1 ABCB11	1.24e-03	9	176	2	DOID:1485 (implicated_via_orthology)
Disease	familial Mediterranean fever (is_implicated_in)	CYP3A4 ABCB1	1.24e-03	9	176	2	DOID:2987 (is_implicated_in)
Disease	BMI-adjusted waist circumference, forced expiratory volume	DIS3L2 PTPN11	1.24e-03	9	176	2	EFO_0004314, EFO_0007789
Disease	1-palmitoyl-2-oleoyl-GPI (16:0/18:1) measurement	DOCK7 PCOLCE2	1.24e-03	9	176	2	EFO_0800439
Disease	alcohol dependence (implicated_via_orthology)	INSRR IGF1R	1.24e-03	9	176	2	DOID:0050741 (implicated_via_orthology)
Disease	encephalitis (biomarker_via_orthology)	ABCB1 IL1RN	1.24e-03	9	176	2	DOID:9588 (biomarker_via_orthology)
Disease	androstenediol (3beta,17beta) disulfate (1) measurement	CYP3A7 CYP3A4	1.24e-03	9	176	2	EFO_0800278
Disease	cholesteryl esters to total lipids in very large HDL percentage	SCGN CELSR2 DOCK7	1.29e-03	36	176	3	EFO_0022257
Disease	dilated cardiomyopathy (implicated_via_orthology)	PPCS DICER1 PTPN11 CTSV	1.36e-03	80	176	4	DOID:12930 (implicated_via_orthology)
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	NRCAM SCGN ABCA8 GSTA1 CELSR2 DOCK7 DOCK6	1.40e-03	276	176	7	EFO_0004612, EFO_0020943
Disease	Colorectal Neoplasms	CPAMD8 NRCAM ABCA8 ABCB1 BUB1 ABCD4 ABCB11	1.43e-03	277	176	7	C0009404
Disease	lung non-small cell carcinoma (is_implicated_in)	ABCB1 BRCA1 FH IL1RN CDK6	1.51e-03	139	176	5	DOID:3908 (is_implicated_in)
Disease	BMI-adjusted waist-hip ratio, asthma	FOXA3 SIK2	1.54e-03	10	176	2	EFO_0007788, MONDO_0004979
Disease	Graves ophthalmopathy (is_implicated_in)	IL1RN IL23R	1.54e-03	10	176	2	DOID:0081120 (is_implicated_in)
Disease	4-androsten-3alpha,17alpha-diol monosulfate (3) measurement	CYP3A7 CYP3A4	1.54e-03	10	176	2	EFO_0022090
Disease	3-phenylpropionate hydrocinnamate measurement	ACSM5 ACSM2A	1.54e-03	10	176	2	EFO_0021010
Disease	1-stearoyl-2-oleoyl-GPI (18:0/18:1) measurement	DOCK7 PCOLCE2	1.54e-03	10	176	2	EFO_0800469
Disease	5alpha-androstan-3beta,17alpha-diol disulfate measurement	CYP3A7 CYP3A4	1.54e-03	10	176	2	EFO_0800289
Disease	Parkinson Disease	ABCB1 GSTA4 IGF1R HSPA9	1.70e-03	85	176	4	C0030567
Disease	lipoprotein measurement, phospholipid measurement	CELSR2 DOCK7 ABCB11 DOCK6	1.70e-03	85	176	4	EFO_0004639, EFO_0004732
Disease	cholesterol in very small VLDL measurement	HMGCR CELSR2 DOCK7	1.75e-03	40	176	3	EFO_0022231
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	HMGCR SCGN CELSR2 DOCK7	1.78e-03	86	176	4	EFO_0008595, EFO_0020945
Disease	apolipoprotein A 1 measurement	MLXIP FOXA3 ABCA8 GSTA2 PTPN11 SLC12A3 CELSR2 NANS CGN DOCK7 ABCB11 DOCK6 CDH16	1.80e-03	848	176	13	EFO_0004614
Disease	DNA repair protein RAD51 homolog 4 measurement	CYP3A7 CYP3A4	1.88e-03	11	176	2	EFO_0801531
Disease	sleep disorder (implicated_via_orthology)	INSRR IGF1R	1.88e-03	11	176	2	DOID:535 (implicated_via_orthology)
Disease	androstenediol (3beta,17beta) monosulfate (2) measurement	CYP3A7 CYP3A4	1.88e-03	11	176	2	EFO_0800295
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	HMGCR FOXA3 ABCA8 SLC12A3 CELSR2 DOCK7 DOCK6	1.89e-03	291	176	7	EFO_0008317, EFO_0020946
Disease	obesity (implicated_via_orthology)	MKKS FAT4 PLXNB2 ITPR1 ALMS1 GNL3	1.89e-03	215	176	6	DOID:9970 (implicated_via_orthology)
Disease	Kidney Diseases	FABP4 SLC12A3 IL1RN IL33	1.93e-03	88	176	4	C0022658
Disease	free cholesterol to total lipids in very small VLDL percentage	HMGCR CELSR2 DOCK7	2.16e-03	43	176	3	EFO_0022290
Disease	sleep duration, low density lipoprotein cholesterol measurement	HMGCR CELSR2 DOCK7 QTRT1	2.18e-03	91	176	4	EFO_0004611, EFO_0005271
Disease	apolipoprotein B measurement	OPA3 HMGCR ABCA8 ABCB1 PTPN11 CELSR2 DOCK7 ABCB11 PCOLCE2 QTRT1 DOCK6	2.20e-03	663	176	11	EFO_0004615
Disease	methionine sulfone measurement	CYP3A4 ALMS1	2.24e-03	12	176	2	EFO_0800072
Disease	dementia (is_implicated_in)	HMGCR IGF1R	2.24e-03	12	176	2	DOID:1307 (is_implicated_in)
Disease	brain disease (is_implicated_in)	RANBP2 UNC93B1	2.24e-03	12	176	2	DOID:936 (is_implicated_in)
Disease	Congenital myopathy (disorder)	NEB TNNC2	2.24e-03	12	176	2	C0270960
Disease	5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement	CYP3A7 CYP3A4	2.24e-03	12	176	2	EFO_0800291
Disease	cholesterol in medium VLDL measurement	HMGCR CELSR2 DOCK7	2.31e-03	44	176	3	EFO_0022225
Disease	total lipids in very small VLDL measurement	HMGCR CELSR2 DOCK7	2.46e-03	45	176	3	EFO_0022156
Disease	phospholipids:total lipids ratio	HMGCR SCGN ABCA8 CELSR2 DOCK7 DOCK6	2.48e-03	227	176	6	EFO_0020946
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	HMGCR SCGN ABCA8 GSTA2 CELSR2 DOCK7 DOCK6	2.54e-03	307	176	7	EFO_0004612, EFO_0020946
Disease	level of Phosphatidylinositol (18:1_18:1) in blood serum	DOCK7 DOCK6	2.64e-03	13	176	2	OBA_2045159
Disease	common cold (is_marker_for)	IL1RN IL33	2.64e-03	13	176	2	DOID:10459 (is_marker_for)
Disease	androstenediol (3alpha, 17alpha) monosulfate (3) measurement	CYP3A7 CYP3A4	2.64e-03	13	176	2	EFO_0800293
Disease	5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement	CYP3A7 CYP3A4	2.64e-03	13	176	2	EFO_0800284
Disease	systemic lupus erythematosus (is_marker_for)	IL1RN IL23R VCAM1	2.79e-03	47	176	3	DOID:9074 (is_marker_for)
Disease	free cholesterol in small VLDL measurement	HMGCR CELSR2 DOCK7	2.79e-03	47	176	3	EFO_0022272
Disease	free cholesterol in very small VLDL measurement	HMGCR CELSR2 DOCK7	2.79e-03	47	176	3	EFO_0022275
Disease	free cholesterol in medium VLDL measurement	HMGCR CELSR2 DOCK7	2.79e-03	47	176	3	EFO_0022269
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	GSTA2 CELSR2 DOCK7 ABCB11	2.96e-03	99	176	4	EFO_0004611, EFO_0007878
Disease	nephroblastoma (is_implicated_in)	DIS3L2 IGF1R	3.07e-03	14	176	2	DOID:2154 (is_implicated_in)
Disease	X-21470 measurement	CYP3A7 CYP3A4	3.07e-03	14	176	2	EFO_0800817
Disease	5alpha-androstan-3alpha,17alpha-diol monosulfate measurement	CYP3A7 CYP3A4	3.07e-03	14	176	2	EFO_0800283
Disease	diabetic neuropathy (implicated_via_orthology)	INSRR IGF1R	3.07e-03	14	176	2	DOID:9743 (implicated_via_orthology)
Disease	cholesterol in medium LDL measurement	HMGCR CELSR2 DOCK7	3.14e-03	49	176	3	EFO_0022224
Disease	cholesteryl esters to total lipids in small VLDL percentage	HMGCR CELSR2 DOCK7	3.14e-03	49	176	3	EFO_0022256
Disease	low density lipoprotein cholesterol measurement, alcohol drinking	GSTA2 CELSR2 DOCK7 ABCB11	3.30e-03	102	176	4	EFO_0004329, EFO_0004611
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	SCGN ABCA8 SLC12A3 CELSR2 DOCK7 DOCK6	3.48e-03	243	176	6	EFO_0004612, EFO_0020944
Disease	phospholipids in very small VLDL measurement	HMGCR CELSR2 DOCK7	3.52e-03	51	176	3	EFO_0022300
Disease	cholesterol to total lipids in small HDL percentage	SCGN CELSR2 DOCK7	3.52e-03	51	176	3	EFO_0022240
Disease	cholesterol to total lipids in small VLDL percentage	HMGCR CELSR2 DOCK7	3.52e-03	51	176	3	EFO_0022242
Disease	1,3,7-trimethylurate measurement	GSTA1 GSTA2	3.53e-03	15	176	2	EFO_0021172

Protein segments in the cluster

Peptide	Gene	Start	Entry
QVAKMINLMRPGVFT	PTPRG	1381	P23470
SMFTPEQIMGKDVRL	USH1C	441	Q9Y6N9
TGMILPTKAMATQEL	AHSA2P	161	Q719I0
EKVMPQGLVISFAMR	BUB1	886	O43683
AGKMSIPMDGTAVIT	CCIN	406	Q13939
KTEFTQGMILPTMNG	AHSA1	156	O95433
IGLDSRGFIPVNKMM	AIFM3	441	Q96NN9
LMKAVATVGPISVAM	CTSV	236	O60911
ALSPLQVKGGVSMMG	BAZ2B	1616	Q9UIF8
LIFMPGTIQMKSTDI	ACSM2A	131	Q08AH3
KQPLGIVMEFMANGS	ANKK1	91	Q8NFD2
IVKITGDMTMSFPSG	FCHO2	566	Q0JRZ9
EVMENKRPGTLVMTL	FAT4	3516	Q6V0I7
IVEVKMLSGFSPMEG	A2ML1	1366	A8K2U0
SGTIGNKIIIPMMTV	ALMS1	2396	Q8TCU4
GSIKMRVFLSGMPEL	AP1M1	196	Q9BXS5
MQTGVGMSLAIPVEV	CCNJ	331	Q5T5M9
LNMVIKPGEMTALVG	ABCB11	441	O95342
MRTGTVMIPGVTQLT	ACSM5	136	Q6NUN0
IPRGTIGDMMQKLSG	CUEDC2	71	Q9H467
LKMIISTMEPQVSNG	ELAVL4	6	P26378
GVPTETIKDMMFQLL	CDK6	116	Q00534
QLNGVMPIAMSIKAG	CELSR2	2891	Q9HCU4
LGTVVNKTLMGPIVM	ABCD4	196	O14678
MGKTIEGITVTVHMP	AP3M1	301	Q9Y2T2
GVVMSSVKMLQPRLS	DIAPH2	781	O60879
MPGTTDTIQVLKGRM	DICER1	1261	Q9UPY3
GPLESEAMVMGILKQ	DIS3L2	766	Q8IYB7
VSTQNMKMGGLPRTT	ABI2	161	Q9NYB9
ITPDMTLQNMKGTER	RANBP2	2386	P49792
PMVEIDGMKLVQTRA	GSTA1	56	P08263
PMVEIDGMKLVQTRA	GSTA5	56	Q7RTV2
KFMKTIPGTALVEMG	HNRNPLL	366	Q8WVV9
VETIRVSLQGKPMMS	PARP9	256	Q8IXQ6
IFIAPVGISTAMGMI	SERPIND1	151	P05546
GGISMLIVVPHKMSG	SERPIND1	351	P05546
PIIAIAGVVEMKMLS	ABCB1	866	P08183
VLQGMVGMIPVSVVG	NPAT	941	Q14207
MGKTIEGVTVTSQMP	AP3M2	301	P53677
IGVTLMEPLTKMTGT	MKKS	316	Q9NPJ1
TGMLNSRVIEIMQKP	MMP7	71	P09237
DTMKMAVVLVTPLGN	LCNL1	16	Q6ZST4
PTVLFEKMGVGRLDM	MAP1S	381	Q66K74
QIITQPETTMAMVGK	LRIG1	496	Q96JA1
PMTSAMGKGTVAVQE	NEDD1	356	Q8NHV4
SGPMMIITQKITSLA	MBOAT2	131	Q6ZWT7
LDIPGTIRKQTFMAM	NLRC4	221	Q9NPP4
MQHIMGPVTAIKLLG	MEPE	151	Q9NQ76
SRMKPATMVFINVVG	MFSD4A	371	Q8N468
TMKPGTGTLIINIMS	NRCAM	96	Q92823
MTQVVLRGGGFLPMT	ITPR1	941	Q14643
PKNLRGMVGTMTEVF	SLC2A7	161	Q6PXP3
PVTQRVKMIMSLGLV	HMGCR	251	P04035
VLMFEMLTGTLPFQG	RPS6KA3	256	P51812
VMSTVGSRKEMPLLQ	LRRC53	366	A6NM62
LKVEMMAGGTQITPL	NCR3LG1	26	Q68D85
RFVMKTLMTICPGTV	KCNN1	271	Q92952
VEINGMFIPKGVVVM	CYP3A4	381	P08684
PMVEIDGMKLVQTRA	GSTA2	56	P09210
PMVEIDGMKLVQTRA	GSTA3	56	Q16772
QGQPTLVIMELMTRG	IGF1R	1071	P08069
KSTPVMIITEFMENG	EPHB2	691	P29323
KSTIGGQIMFLTGMV	GSPT2	216	Q8IYD1
ESGSIFKGQQLVMMP	GSPT2	451	Q8IYD1
LLKFMEPVTMQESGT	PLXNB2	706	O15031
TKMRIMGFRGTVIKP	OPA3	56	Q9H6K4
ISVTVPKMLLDQVMG	OR2T4	106	Q8NH00
KGVGVFMTVINPMLN	OR3A3	281	P47888
LTIPESSTVKGMMAG	GLYR1	181	Q49A26
AMSRGTIMFKVVPVS	MPP4	221	Q96JB8
MTKTLPGGIMVNGSR	GBP5	276	Q96PP8
MTGSPTLVKNMISGL	FOXP4	551	Q8IVH2
VLMFEMLTGTLPFQG	RPS6KA6	261	Q9UK32
RPGALVSSGNKMMVQ	PCOLCE2	111	Q9UKZ9
PKTIQMVRSQRSGMV	PTPN11	491	Q06124
MVVIDVKMLSGFTPT	OVOS2	1346	Q6IE36
IGVMLPQVLKGMTSE	MSH6	651	P52701
LVTGPNMGGKSTLMR	MSH6	1131	P52701
GEVILVGGMTRMPKV	HSPA9	381	P38646
VGGMTRMPKVQQTVQ	HSPA9	386	P38646
MKMADRSGKIIPGQV	ARHGAP12	1	Q8IWW6
ASGVGVPIMVMAVTR	OPRD1	176	P41143
QLMSKFGIIMRDPQT	HTATSF1	151	O43719
IQSSGGPLQITMKMV	PPCS	196	Q9HAB8
AVIMTSGPLKREGML	MLXIP	586	Q9HAP2
AGSEMQIRPIVMSQK	OPN3	341	Q9H1Y3
MIMPSALQEKGVTTS	ARHGAP29	1096	Q52LW3
VNKRMSMVVSGLTPE	BRCA1	1646	P38398
PMVEIDGMKLVQTRS	GSTA4	56	O15217
GVDGKMLMVTLSPTK	IL33	176	O95760
MMLSRAKPAVGRGVQ	TTC26	1	A0AVF1
KVVSMLQGSGAMPTL	GRID2IP	336	A4D2P6
TRKLGFSNIIMPGEM	DOCK4	386	Q8N1I0
DAKMLQMVLQGSVGP	DOCK6	1926	Q96HP0
ADPKMLQMVLQGSVG	DOCK7	2016	Q96N67
ISTQIRMEVGPTMVG	GCHFR	6	P30047
TMNFKIGGVTERMPT	FH	76	P07954
FGKPVAGALMINMTV	CPAMD8	256	Q8IZJ3
VKVTLLNFMITPEGM	DNAH7	3096	Q8WXX0
TIIMEGMPVGTKLTQ	FAT3	2821	Q8TDW7
VEPATIFKMGMNISI	IL23R	36	Q5VWK5
MAITFNGLTPQKMEV	C1GALT1C1L	271	P0DN25
GDTGVMQIPKNLLEM	DENND5B	966	Q6ZUT9
PVKMQAGIATPGMKT	CCDC57	866	Q2TAC2
PVGQMGTVKYVLMSA	BPIFB6	196	Q8NFQ5
AMQVPVVMTSLGQKI	ELF2	391	Q15723
QGQPTLVIMELMTRG	INSRR	1051	P14616
IMGTKFPMELGIRVG	EFHB	21	Q8N7U6
VQLIMGMLSEKPRSG	INSC	461	Q1MX18
MGLTRSMQVVPLDKQ	GNL3	286	Q9BVP2
VFMGTQVPKGAVMFV	KLF10	306	Q13118
TMSPQEVEGLMKQTV	CUL9	1996	Q8IWT3
VSLTNMPDEGVMVTK	IL1RN	156	P18510
MKGNVTNVLPMILIG	EMC3	111	Q9P0I2
MAKPNMIISVNGDVI	FABP4	36	P15090
KIVTDDMPIFMGLIG	DNAH9	2081	Q9NYC9
VEINGMFIPKGVVVM	CYP3A7	381	P24462
FAGPVVLVIVMNGTM	CELSR3	2686	Q9NYQ7
LQMFIGVVDIPAKMG	SLC22A12	381	Q96S37
PTVLRMTAVGLGQMA	SLC22A12	461	Q96S37
VKDMMELVQPSISGV	SCGN	226	O76038
AELVTPMLKEGGISM	EIF4G3	1321	O43432
DIKGNNVMLMPTGII	MAP3K19	1186	Q56UN5
RMKGMPTKLSAVGIL	CDH16	776	O75309
LRVSMSPGDQVMEGK	CD22	596	P20273
LDMLKQTGRPEMVVG	PSMD14	96	O00487
GDKPMTQRALTVLMV	FAM174A	116	Q8TBP5
KMIPGVVDTGLFINM	RPIA	276	P49247
MPGKMVVILGASNIL	VCAM1	1	P19320
MPVGTQATMKGITTE	QTRT1	46	Q9BXR0
ESQEMPMGRTILKVT	FILIP1	1026	Q7Z7B0
FTLVGMKMLQAPESV	NME4	66	O00746
GIRMVNMKSKEPAVG	OVCH1	26	Q7RTY7
IGVGTPGIMKDMLSA	HMGCL	206	P35914
LRAQVMEVKALPGMG	EIF5B	856	O60841
MEVKALPGMGTTIDV	EIF5B	861	O60841
ITMAIQQAPGKMLTL	FOXA3	126	P55318
EEMPTTVLQSMKLGV	STRIP1	551	Q5VSL9
PIKNEVASGMILVMA	STT3A	451	P46977
QLVVMPGAGKIFSMN	SIK2	491	Q9H0K1
PTRVMILTAVKEMNG	SHPRH	441	Q149N8
TAKKGRPMVISSGMQ	NANS	146	Q9NR45
EMNLPTVSALRKMGV	PYCR2	36	Q96C36
QVNPISKRMGPMTVV	RHOBTB1	386	O94844
VSGPELAAMMKIGTR	HERC2P3	586	Q9BVR0
VISVMGNLGMIVLTK	OR8K3	36	Q8NH51
MKTPVELAVSGMQTL	RITA1	1	Q96K30
KIQDVGLVPMGGVMS	MRPL12	91	P52815
SMTMLFLPVTGTLKQ	SEMA3D	26	O95025
MDIVSNGLLGMVKPS	ABCA8	986	O94911
LIFMPGTIQMKSTDI	ACSM2B	131	Q68CK6
LEKMQPLVMVSSGST	CGN	341	Q9P2M7
VMKISPEQGLQFSRM	CLTCL1	521	P53675
NVTMAGKEVFLVMPT	RECQL	101	P46063
GPTLVMDIKMQIGSR	RNASE13	16	Q5GAN3
VLPEKRTATVGGAMM	SF3B2	786	Q13435
DIDSKMLMGINVTPI	UNC93B1	106	Q9H1C4
QIMKSIIPVVMAGII	ATP6V0C	51	P27449
RTGTLEFMAPEMVKG	SPEG	3121	Q15772
MSPMVVETLKLGIAI	RYR3	3641	Q15413
MKGVSENIMLGQLAP	POLR2A	1451	P24928
MFNLIVGTGALTMPK	TMEM104	21	Q8NE00
GPFLVMVLIQFGTMV	PIEZO2	2231	Q9H5I5
GPFTIMIQKMIFGDL	TRPV6	516	Q9H1D0
AVLGKTSPTQMLIMT	RHAG	131	Q02094
VQILMQAAGLGRMKP	SLC12A3	721	P55017
MRGKLGVSPRMVTVN	SLC6A11	596	P48066
EMIIQPGIAKANMGV	TBC1D13	76	Q9NVG8
TVMAAAPAGMKGITQ	RFX7	166	Q2KHR2
VSIPKLEISMMQGFA	PSME4	106	Q14997
GKFNMVIPLVDGMIV	RALGAPB	1411	Q86X10
VVAGRSKNVGMPIAM	MTHFD2L	211	Q9H903
MTPKIVMFTIDIGEA	TMED2	101	Q15363
GTVMRMLGQTPTKEE	TNNC2	41	P02585
GTPMDVKAGVRVMQV	WDR62	486	O43379
KMMEQGPVLIITFQA	TIMM44	381	O43615
GSNMVVPQAKMALVL	ZZEF1	1231	O43149
TGMLPKRYTQGVMTG	SLC29A4	191	Q7RTT9
MGQEKLTGPALMAVE	ZMYM1	1101	Q5SVZ6
VSTILEKPQNMMVVG	ITFG1	246	Q8TB96
GVPVMAIRNKMISEG	WASHC3	146	Q9Y3C0
KENMETGTGLTPVMT	PRR11	316	Q96HE9
MSQGGMVTVIPATVV	TOX4	381	O94842
GPFTIMIQKMIFGDL	TRPV5	476	Q9NQA5
MVMTIVVPIGGQLAD	SLC17A8	361	Q8NDX2
GKSPVNMVTVAMVAG	ZNF649	481	Q9BS31
HLGPTVGRTKMEMFV	TMPPE	216	Q6ZT21
NQKMRPGSGMLSIRV	VPS13D	3766	Q5THJ4
DKGIGMGMTVPISFA	HEBP1	71	Q9NRV9
TPMNLPKLMVVVGGQ	KLHL2	301	O95198
RIKSMFLQMGTTAGP	PPP1R9B	56	Q96SB3
GTAIGKTPEMMRVKQ	NEB	6161	P20929
LNINMTSPMGTKSIL	PCSK2	521	P16519